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Examination of the transcriptional messages encoded in the manifold of mRNA 
molecules within a cell is a central task of molecular biology and functional genomics.  
This examination can be broken down into two parts: collection of gene expression data, 
and analyses of those data.  Here, a new method for collecting gene expression data, and 
two new methods for analyzing those data are presented. 
A new method for quantifying gene expression denoted as the Mass-spectrometric 
Analysis of Gene Expression (MAGE) is developed. MAGE relies on novel conjugates of 
DNA oligonucleotide 30-mers; each unique sequence is conjugated via photolabile linker 
to an N-substituted glycine oligomer (peptoid) of unique mass.  Deuterated bromoacetic 
acid is incorporated into some peptoids yielding two chemically identical probe 
conjugates of different molecular weights for each nucleic acid sequence of interest.  
Mixtures of these probes, along with 3' adjacent biotin-labeled oligonucleotides, are used 
to interrogate a target mixture of cDNA.  Following hybridization, the two adjacent 
probes are ligated to enhance the specificity of the identification, and to enable the use of 
a biotin-affinity column for removal of confounding peptoid tags.  The resulting mixture 
is exposed to longwave ultraviolet light to release the peptoid tags, that are quantified 
using MALDI-TOF mass spectrometry using the isotopically labeled peptoids as internal 
standards.  These individual components of MAGE are demonstrated.   
 A strategy for simplification and visualizing of high-dimensional gene expression 
data, as well as a strategy for inferring the presence of clusters within those data, is 
 viii 
formulated and implemented.  In order to visualize high-dimensional gene expression 
data, principle components analysis is used with subsequent mapping of the data onto an 
orthogonal set of basis functions known as Andrews curves.  This analysis method is 
demonstrated by visualizing of breast cancer tumor data and yeast sporulation data. In 
order to cluster gene expression data, the expectation-maximization algorithm is 
employed to optimize the parameters of a mixture model of Lorentzian distributions.  The 
difference between Lorentzian and Gaussian mixture models is first demonstrated with 
artificial data, and then applied to yeast sporulation data.  The results indicate that 
mixtures of Lorentzian distributions may have significant utility for gene expression 
analysis. 
The tools demonstrated here offer unique advantages when compared to the 
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Gene expression analysis is the examination of the transition of information 
encoded in nuclear DNA to the collection of proteins that are the ultimate product of that 
DNA.  The central dogma of molecular biology, Figure 1.1, describes the flow of cellular 
information in general terms, originating in the genome where information is encoded in 
DNA molecules.   
 
Figure 1.1: The central dogma of molecular biology. This schematic representation of 
the central dogma suggests the importance of studying the transcriptome. 
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In the nucleus, DNA is transcribed into a complementary manifold of mRNA 
molecules, known as the transcriptome.  These messages are subsequently transported to 
ribosomes where transcripts are translated into proteins.   The transcriptome is not a copy 
of the genome, because only portions of the genome are transcribed.  The selection of 
which and extent to which genes are transcribed is largely a function of the state of the 
proteome, which acts in part to regulation of gene expression.  The state of the 
transcriptome is thus a function of the basic information content of the genome, the 
regulatory action of the proteome, and also the proteome-mediated degradation of 
transcripts.  Finally, the state of the proteome is a function of, among other things, the 
transcripts that reach the ribosomes.  The proteome, which harbors the enzymes that 
catalyze the reactions inside the cell, is also subject to self-modification and modification 
from information inputs from outside the cell. 
A basic experimental need of functional genomics is the ability to measure the 
abundance of identifiable sequences of either mRNA or DNA derived from mRNA.  
Although the relationship between the transcriptome and its product, the more 
functionally diverse proteome, is not yet fully understood1-3, it has been repeatedly 
demonstrated that even in isolation, the transcriptome is an information-rich molecular 
phenotype.   
Recently, transcriptome analysis has been applied to the classification of breast 
cancers4, prostate cancers5, adult acute myeloid leukemias6, and follicular thyroid 
tumors7, where significant clinical factors such as time to distant metastasis and overall 
survival are correlated to the abundances of a subset of the transcriptome.  Another class 
of studies has sought to infer relationships among genes or proteins by examining 
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changes in gene expression for a particular organism or tissue across a relevant range of 
conditions.  This has been the aim of studies of yeast sporulation8, stress response in 
human cell culture9, and C. elegans development10.    Another intriguing class of studies 
seeks to determine the quantitative behavior of subsets of the transcriptome11-15.  Unlike a 
general classification or identification analysis, efforts to model gene regulation networks 
demand highly quantitative data on a gene-by-gene basis.  This demand is often met by 
using large-scale data to initiate a framework for analysis, and then conducting as many 
lower-level analyses using more precise, but time-consuming, methods as are practical16.   
Sequence-specific nucleic acid detection has been a fundamental technique of 
molecular biology for decades17,18.  The current state-of-the-art techniques that are 
designed to be quantitative can largely be categorized into several classes: PCR-based, 
sequencing-based, and microarray-based.  Because they incorporate exponential 
amplification, PCR-based methods, such as real-time PCR and competitive PCR, are 
currently the most sensitive techniques available.  The sequencing-based methods, such 
as serial analysis of gene expression (SAGE) and differential display, are principally 
advantageous when the genes or sequences of interest are not known before the 
experiment.  Microarrays require advanced knowledge of sequences of interest, but they 
make practical the simultaneous analysis of thousands of sequences.  Of these methods, 
only SAGE is inherently quantitative, but it cannot be applied to rarer transcripts in a 
statistically robust manner with today’s sequencing technology.  Thus, clever methods of 
normalizing the other technologies have been devised in order to provide quantitative 
data. 
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In order to make PCR quantitative, the sequence of interest (SOI) is amplified 
along with a sequence of known initial abundance.  In the case of real-time PCR19-21, the 
focus is to eliminate all of the variability in PCR that comes after the exponential phase, 
by employing fluorescent labels to monitor the PCR reaction kinetics and using an 
intermediate, exponential-phase abundance for the calculation.   In a simple example, the 
sample to be analyzed is divided into two aliquots, and in one aliquot the SOI is 
amplified, and in the other aliquot an endogenous comparator sequence is amplified.  The 
comparator sequence is chosen to have a constant abundance across all of the samples to 
be analyzed.  So-called housekeeping genes are generally candidates for comparator 
sequences. 
In competitive PCR22,23, the comparator sequence is exogenous, and is exactly the 
same as the SOI with the exception of a one-base mismatch.  The SOI and a known 
amount of comparator are co-amplified by the same primers in the same reaction, and 
because of their similarity, they are amplified at the same rate as long as their starting 
concentrations are fairly similar.  Here, the difficulty lies in quantifying the relative 
amounts of two nearly identical sequences.  The most sophisticated way to do this yet 
proposed is the method of Ding and Cantor23, where a base extension reaction is used to 
produce two small oligodeoxynucleotides (ODNs) of different masses in known 
proportion the relative abundances of the two amplified sequences.  These ODNs are then 
quantified by MALDI-TOF mass spectrometry.  This technique does not require the 
expensive fluorescent tagging systems that real-time PCR does, but neither PCR-based 
technique is suitable for significant multiplexing in a laboratory of typical resources. 
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Serial analysis of gene expression (SAGE) employs enzymatic techniques to 
create short tags from a pool of cDNA that are subsequently concatenated, cloned into 
plasmids, and sequenced24.  SAGE is inherently quantitative, and thus very well suited 
for multi-laboratory collaboration.  However, due to the fundamental statistics of gene 
expression, Table 3.1, even if 105 tags are sequenced, rare transcripts are not reliably 
quantified.  Differential display, unlike the other methods discussed here, does not 
require expensive consumables or equipment.  Differential display functions by using 
PCR primers designed to hybridize to a small fraction of the sequences in a typical cDNA 
sequence, and amplify only those25,26.  The typically 50-100 products are displayed using 
gel electrophoresis, and sequences that are differentially displayed between two samples 
can be isolated and sequenced.  Depending on how rigorously the labeling process is 
handled, this method can determine relative abundances of SOIs, but it cannot approach 
the reliability of the low-throughput PCR methods. 
 
 Copies per Cell 
of Each mRNA 
sequence 
 Number of Different 
mRNA Sequences in 
Each Class 
 Total Number of mRNA 
Molecules in Each Class 
Abundant 
class 
12,000 X 4 = 48,000 
Intermediate 
class 
300 X 500 = 150,000 
Scarce class 15 X 11,000 = 165,000 
Table 1.1: Distribution of mRNA in a cell.  In a typical cell, the majority of genes are 
expressed as scarce transcripts.  A single scarce gene might only make up .001% of the 
total transcript population27. 
 
 Microarrays are surfaces onto which probe sequences are spatially arranged at 
high density.  Labels are incorporated into the target sequences, and then the targets and 
probes are contacted and allowed to hybridize.  After washing, the microarray is 
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visualized, and the resulting display in combination with the spatial map of sequences on 
the surface indicates which sequences were present in the target.  A carefully controlled 
system of fluorescent labeling can confer quantitativeness to microarray methodologies.  
Three types of microarrays account for the majority of studies: short-ODN, long-ODN, 
and cDNA.  Short-ODN microarrays28,29 are composed of multiple different probe ODN 
sequences for each target SOI.  Because the length of the probe ODNs is typically no 
more than 25 nucleotides, single-base mismatch controls and sophisticated statistical 
techniques are employed to produce aggregate quantitative figures.  Long-ODN 
microarrays rely on probe ODNs that are composed of at least 50 nucleotides, and thus 
have fewer problems with cross-hybridization compared to short-ODN microarrays.  The 
longer ODNs can be synthesized in situ30, non-specifically immobilized31, or covalently 
attached32 to the surface.  Most microarray studies rely on robotically spotted cDNA 
microarrays8,33, where the probes are either full-length cloned cDNAs or large PCR-
amplified fragments that are robotically deposited on the surface in a non-specific 
manner.  Typically, the target mRNA pool from one of two samples being compared is 
labeled during reverse transcription with the dye Cy3, and the other with Cy534.  The two 
target samples are simultaneously hybridized to the same probe array, and the intensity of 
each spot is measured at wavelengths appropriate for each dye.  The relative abundance 
of the target SOIs is inferred from these intensities.  Recently, a method has been 
developed to combine stringent labeling procedures with printed dye calibration spots in 
order to produce absolute abundances from microarray data35. 
 Microarray experiments do not include an inherent amplification step, however a 
variety of global amplification schemes have been tested with varying degrees of success.  
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Two of the most popular methods are linear amplification schemes that offer significantly 
more reproducibility than global PCR-based schemes: in vitro transcription36 and the 
aRNA-based method of Eberwine37-39.  Using these methods, the minimum starting 
material requirement for microarrays can be lowered to about one µg of total RNA, or the 
amount found in 105 to 106 cells, which is still far more than is required for PCR-based 
methods. 
 Microarrays are most often employed as screening tools.  Successful studies have 
sought to use the aggregate data for broad classification40 or to identify genes with 
behavior worthy of further investigation41. In either case, false information will generally 
not confound the overall result of a meaningful classification or a collection of genes of 
interest.  Improving microarray methodology in order to maximize reproducibility42-44, 
and formulating statistical models to extract the maximum amount of relevant 
information from each experiment45-47 are major areas of research.  This work is hindered 
by an incomplete understanding of the physics of hybridization between free ODNs and 
tethered ODNs48-50, as well as the sources of noise in gene expression analysis51-54.  
Because of this, it is common for studies to verify particular microarray results with low-
throughput, high-fidelity methods, most commonly real-time PCR55.  These subsequent 
studies are often critical because many significant biological processes are affected by 
relatively small changes in abundance of relatively scarce transcripts.  Another reason 
that PCR methods are important supplements to microarray studies is that although 
fluorescent detection systems in principle operate over 4-5 orders of dynamic range, in 
practice microarrays experience signal compression, signal deterioration, and floor 
effects when operated beyond 2-3 orders of dynamics range56,57. 
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 There remains a need for new methods for gene expression analysis, or the more 
general problem of sequence-specific nucleic acid quantification, especially for 
addressing the problem of efficiently collecting very reliable, unambiguously quantitative 
data for 5-50 SOIs, with the sensitivity and dynamic range of PCR-based methods.  Such 





For functional genomics studies, there is a need to first quantify the state of these 
groups of molecules and then extract from this mass of data functional information about 
either the correlation between the measured state and some other phenotypic 
characteristic, or more profoundly, the fundamental interactions, control loops, and 
kinetics at work.  Thus, gene expression analyses comprise two major efforts: the 
collection of useful information from the transcriptome, and the processing of data in 
some meaningful way.  This thesis introduces a new method for collecting data in 
Chapter 3, and two new methods for processing data in Chapter 4.  One of the key 
components of the new method of data collection is a class of sequence-specific 
heteropolymers that contain conjugates of DNA oligonucleotides and peptoids.  During 
the course of investigations, I compiled a collection of synthetic tools for engineering the 




1.2.1  Collecting Gene Expression Data 
 
The number of transcripts that exist from a particular gene at any time is a 
measure of how actively that gene is being transcribed and how quickly the transcript is 
subsequently being degraded.  Although there is not a 1:1 correlation between transcript 
abundance and protein abundance, measurements of mRNA species are considered to be 
measures of the extent of gene expression.  The transcriptome contains a wide variety of 
mRNA species.  The majority of genes in the genome are expressed in very small 
quantities, Table 1.1.  Furthermore, many of the very tightly regulated genes that are of 
great interest, are in this scarce category.  This distribution must be taken into account in 
the design of any transcript quantification method. 
 Transcripts are molecules of mRNA, and the goal of transcript quantification is to 
create an inventory listing transcripts by what protein they code for, and the abundance of 
each of these species.  Some methods inventory only one transcript at a time, some 
inventory a large, predefined list, and still others inventory all transcripts, even those that 
code for genes that have not been identified.  Quantification methods also vary in their 
sensitivity, reproducibility, dynamic range, and ease of use.  Many of the methods can 
only quantify a particular transcript relative to some other transcript.  Other methods 
measure the abundance of transcripts irrespective of a comparator nucleic acid, but no 
method can simultaneously compare nucleic acid concentrations from more than two 
samples. 
 The fundamental property used for the identification and quantification of mRNA 
molecules is each molecule’s sequence.  The sequence of an mRNA molecule is 
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complementary to that of the gene it was transcribed from, so in this manner it can be 
identified with a particular gene. Also, either in its native form or reverse transcribed into 
cDNA, the sequence of the molecule can be put to use by probing for it with a labeled 
complementary nucleic acid, whether it be cDNA (complementary DNA), RNA, or even 
PNA (peptide nucleic acid).  Every assay for mRNA relies on identification by sequence, 
either through hybridization or through direct sequencing. 
 In Chapter 3, I present a method for quantifying the absolute abundance of nucleic 
acid species of a pre-identified sequence using mass spectrometry.  I denote this 
methodology mass-spectrometric analysis of gene expression as MAGE.  Because 
nucleic sequences cannot be discriminated by their mass, I introduce a system of 
hybridizable oligodeoxynucleotide probes conjugated reversibly to peptoid labels serving 
as mass tags.  I engineer the peptoid tags to be optimally suited for mass spectrometric 
quantification.  MAGE is designed to minimize potential sources of error, and rely on 
controllable physical processes, and be parallelizable up to about 50 sequences of 
interest.  Such a method would be useful for medium-scale studies of groups of related 
transcripts, especially for quantitative modeling. 
 
1.2.2  Analyzing Gene Expression Data 
 
 For the past ten years, investigators have been employing new methods of gene 
expression data collection to simultaneously measure the abundance of thousands of 
different species of mRNA.  A typical experiment might measure the abundance of 
transcripts corresponding to 8,000 genes in 20 different biological samples.  Data on this 
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scale are not amenable to conventional statistical tests of significance.  Furthermore, 
many of the hypotheses tested by gene expression experiments are complex or 
unconventional.  At the far extreme of this are experiments designed to suggest 
hypotheses for further testing, when the analytical question becomes “what patterns are 
present in the data that are worth investigating?”  Two major challenges of analyzing 
highly multivariate gene expression data such as these are first to present, or visualize, 
the data in an informative manner, and second to robustly identify patterns, especially 
clusters, in the data.   In Chapter 4 of this thesis, I present one solution to each of these 
problems. 
 Visualization of data becomes a problem when each element of data, or vector, 
grows beyond 2 dimensions; the central issue is mapping vectors in multidimensional 
space onto 2 dimensions.  My solution to this problem is to first apply a method of data 
reduction known as principle components analysis (PCA), and follow that by mapping 
the data onto an orthogonal set of basis functions known as Andrews curves.  This serves 
to convert each high-dimensional vector to a two dimension wavy line.  Two vectors that 
are close to one another in high-dimension space will become two lines with a similar 
wave pattern. 
 Clustering is a task that derives from several basic hypotheses that are frequently 
tested in large-scale gene expression experiments.  One is that genes that have similar 
expression patterns over a range of samples or conditions are likely to be biologically 
related.  Another is that biological samples that have similar patterns of gene expression 
are likely share in some other phenotypes.  Either hypothesis leads to the analytical task 
of clustering, which seeks to identify vectors in high dimensional space that are close to 
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one another.  Our solution to this problem is to apply the expectation-maximization 
algorithm to optimize the parameters of a mixture model.  A mixture model is a 
hypothesis that the data were generated by a linear combination of probability 
distribution functions.  The majority of such models that have been previously studied are 
based on normal distributions, but I present results that indicate that mixtures of 
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2.1  Introduction 
 
Peptoids, Figure 2.1, are N-substituted glycine oligomers, and have become a 
























Figure 2.1: Schematic illustrations of peptoids and peptides. Compared to 
peptides such as oligo-alanine, upper, peptoids, such as oligo-sarcosine, lower, lack 
stereochemistry and sites for hydrogen bonding, but retain a similar spacing and overall 
structure. 
 
Originally proposed by Zuckermann et al.2 as a strategy for synthesizing diverse 
libraries of lead compounds for drug discovery, peptoids have since been designed to 
form stable secondary structures3, including a family of α-chiral-side-chain substituted 
peptoids that form stable helices4-7.  Several studies have shown that peptoids8 or peptoid-
peptide hybrids9,10 can be designed to act as protein ligands in the nanomolar to 
micromolar affinity range.  Kodadek et al. are currently developing methodologies for the 
synthesis of large peptoid libraries and subsequent screening and isolation of peptoid 
ligands from those libraries11. 
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 A number of studies have demonstrated the use of peptoids in other biomimetic 
and biotechnological roles.  Peptoid nucleic acids extend the biomimetic role of peptoids 
beyond that of peptide mimicry12,13.  Peptoids have been designed to serve as cell 
penetrators14,15 and gene delivery vehicles16.  Several studies have demonstrated peptoids 
with antimicrobial properties17,18, including helical mimics of magainin-2 amide19.  
Helical peptoids have also been designed to mimic lung surfactant protein C20, and a 
series of trialkylglycine peptoids have been shown to have analgesic effect by blocking 
VR1 channels21.  Peptoids were also applied as uncharged, water-solubilizing caps for 
use in membrane-interactive peptides22. 
 One of the most attractive features of peptoids is the ease with which diverse, 
relative pure oligomers can be synthesized.  Although several methods for peptoid 
synthesis have been proposed2,23-25, the solid-phase, submonomer method of Zuckermann 
et al.26,27 is the most widely replicated.  The central advantage of the submonomer 
method (Fig. 2.2) is that the growing chain of the peptoid is extended by repeated 
applications of a single linking chemistry, and that the submonomer providing diversity is 
a primary amine (Fig. 2.3).  Perhaps the greatest disadvantage of the submonomer 
method, the requirement of on average 3 hours of reaction time per monomer added to 
the growing chain, has recently been eliminated by Olivos et al.28, who demonstrated 





























5% H2O  
Figure 2.2: The solid-phase submonomer method of peptoid synthesis. This 
method is executed by repeated, alternating rounds of bromoacetylation and primary 
amine substitution.  Commonly, the finished chain is cleaved by trifluoroacetic acid to 






















Figure 2.3: Primary amines used for peptoid synthesis.  Peptoid diversity is 
generated through the choice of primary amines (R-NH2 in Figure 4.2).  Some commonly 
used classes include aromatic, aliphatic, heterocyclic, cationic, anionic, bulky, small, 
hydrophobic and hydrophilic. 
 
 The submonomer synthesis has been extended to allow for a variety of primary 
amine submonomers29, including unprotected heterocycles30.  Depending on the linker 
chosen, peptoids can be produced with either C-terminal acids31 or amides32.  A variety of 
chemoselective functionalities33 can be incorporated into peptoids either along the 
backbone or at the N-terminus, such as aminooxyacetamides, N-
(carbamoylmethyl)acetohydrazides, mercaptoacetamides, 2-
 25
pyridinesulfenylmercaptoacetamides, maleimides34, and aldehydes.  Analysis of peptoids 
is commonly accomplished by RP-HPLC, mass spectrometry35, and capillary 
electrophoresis36,37.  Once synthesized, peptoids can be sequenced by Edman 
degredation38.   
 Here, I seek to further expand the toolkit for peptoid synthesis while staying 
within the submonomer synthetic methodology.  First, I demonstrate a simple method for 
introducing 2:1 branch into the growing peptoid chain.  This would allow the rational 
synthesis of branched or multiply branched structures, and it could also be incorporated 
into a parallel synthesis to generate libraries of branched structures.  Second, I 
demonstrate a simple method for capping the growing peptoid chain.  Capping is a 
standard step in the protected-monomer synthesis of DNA, and caps have found 
application in peptide synthesis as purification tags39-43.  If a particular primary amine 
submonomer had a low rate of substitution during peptoid synthesis, that step could be 
immediately following by the addition of a high-substituting cap.  By doing this, that 
chain would never grow any longer and would not result in a potentially confounding 
single-deletion sequence.  Third, I demonstrate several useful N-terminal modifications, 
including two types of haloacetamides, two types of carboxylic acids, and two types of 
primary amines.  Fourth, I demonstrate a straightforward technique for peptoid 
macrocyclization that is chemically orthogonal with many potential peptoid sequences.  
Because many macrocyclic peptides have potent biological activity44-47, a general method 
for peptoid macrocyclization would expand the potential applications of peptoids.  Fifth, I 
demonstrate the synthesis of two different peptoids incorporating four adamantine 
moieties.  Adamantyl species have not yet been reported as peptoid submonomers 
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because when attached proximal to the growing chain, it can severely hinder chain 
extension.  In my syntheses, adamantane moieties are attached via two different spacers.  
Finally, I demonstrate a new method for conjugating peptoids and DNA 
oligodeoxynucleotides (ODNs).  Peptoid-ODN conjugates have been applied to 
demonstrate a drag-tag methodology for electrophoresis34, but they have not yet been 
applied to biological studies as many peptide-ODN conjugates have. 
 
2.2  Experimental 
 
 2.2.1  General Peptoid Synthesis 
 
Peptoids were synthesized manually using the method of Figliozzi et al.27  The 
synthesis is described here using 100 mg of resin, but up to 250 mg have been 
successfully used in the same size synthesis vessel by scaling all other reagents linearly.  
100 mg of rink amide MBHA resin (Novabiochem, La Jolla, CA) was loaded into a 10 
mL peptide synthesis vessel that had been modified to improve agitation by adding a 
small pocket on the wall of the reaction chamber.  The resin was first washed several 
times with N,N-dimethylformamide (DMF, Aldrich Chemical Co., Milwaukee, WI).  All 
solvents were purchased anhydrous and kept as dry as possible by careful handling and 
storage with molecular sieves (3A, EM Industries, Gibbstown, NJ).  The resin was 
agitated by an upward directed flow of argon.  A wash step refers to adding 1-2 mL of 
solvent, agitating for 30 seconds, then draining the vessel under aspirator vacuum.  
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 After the initial washing to swell the resin, the DMF was drained and the Fmoc 
groups protecting the resin free amines were removed by adding 2 mL of 20% piperidine 
in DMF, agitating for one minute, draining, and adding another 2 mL of 20% piperidine.  
The second solution was agitated for 15 minutes and then drained.  The resin was washed 
with DMF six times before peptoid synthesis. 
 From here, repeated rounds of a single linking chemistry were used (Table 2.1 
and Fig. 2.2).  First, the free amines were acetylated by adding 850 µL of 0.6 M 
bromoacetic acid (BAA, Aldrich Chemical Co., Milwaukee, WI) and 200 µL of 3.2 M 
diisopropylcarbodiimide (DIC, Aldrich Chemical Co., Milwaukee, WI). The slurry was 
agitated for 30 minutes, drained, and an identical solution was added for a further 30 
minutes of agitation.  Following this, the mixture was drained, washed twice with DMF, 
and once with N-methylpyrrolidone (NMP, Aldrich Chemical Co., Milwaukee, WI). 
 The nucleophilic substitution of a primary amine is the second half of a round of 
synthesis.  The primary amine of choice was dissolved at around 1.5 M in NMP and 1mL 
of this solution was added to the vessel.  The mixture was agitated for two hours, drained, 
and the resin is subsequently washed twice with NMP and once with DMF.  Amines in 
acid salt form were first neutralized by the addition of 95% the stoichiometric amount of 
KOH (Aldrich Chemical Co., Milwaukee, WI).  The organic layer was separated and 
used for the synthesis. 
 Once the peptoid was completed (generally by adding the final primary amine) 
the resin was washed thoroughly with DMF (four to six washes) and then 
dichloromethane (four to six washes), and allowed to dry for about an hour in the reaction 
vessel.  Following this, the peptoid was cleaved from the resin by placing the resin into a 
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glass vial containing 5-10 mL of 95% trifluoroacetic acid in water (TFA, Aldrich 
Chemical Co., Milwaukee, WI).  This mixture was stirred for 30 minutes, filtered, and 
washed with further TFA and water.  The resulting solution was diluted with water and 
dried using a rotary evaporator or with a stream of dry nitrogen, subsequently frozen and 
lyophilized.  The dried material was resuspended in one of water, dimethylsulfoxide, or a 
mixture of water and acetonitrile and placed into a tared cryovial for final lyophilization 
and storage. 
 







0.6 M bromoacetic acid 
in DMF 
- 850 - 
2 Activation 3.2 M 
diisopropylcarbodiimide 
in DMF 
- 200 - 
3 Acetylation  30 min  2 








5 Displacement 1.5 M primary amine in 
NMP 
2 h 1000 1 








Table 2.1: Peptoid synthesis single linking chemistry scheme of Figliozzi et al., for 
100 mg of resin.  These steps are repeated for each monomer addition. 
 
 
2.2.2  Specialized Syntheses 
 
I introduced branches by incorporating 1,4-diaminobutane (Aldrich Chemical Co., 
Milwaukee, WI) during the primary amine substitution step.  Two secondary amine 
capping agents were tested, piperidine (Aldrich Chemical Co., Milwaukee, WI) and N,N-
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diethylamine (Aldrich Chemical Co., Milwaukee, WI).  These are also introduced during 
the normal primary amine substitution step. 
The N-terminal modifiers were incorporated by making the final step of peptoid 
synthesis an acetylation, and the modifiers included bromoacetic acid (Fluka, via Aldrich 
Chemical Co., Milwaukee, WI), iodoacetic acid (Fluka, via Aldrich Chemical Co., 
Milwaukee, WI), diglycolic acid (Aldrich Chemical Co., Milwaukee, WI), succinic acid 
(Aldrich Chemical Co., Milwaukee, WI), FMOC-γ-aminobutyric acid (Novabiochem, La 
Jolla, CA), and FMOC-alanine (Novabiochem, La Jolla, CA). 
Macrocyclization was accomplished by creating a free amine near the C-terminus 
of the peptoid using mono-trityl 1,4-diaminobutane acetic acid salt (Novabiochem, La 
Jolla, CA).  The peptoid N-terminus was modified by diglycolic acid, and the post-
cleavage macrocyclization is effected by 3 equivalents of PyBOP (Novabiochem, La 
Jolla, CA), 10 equivalents of DIPEA (Aldrich Chemical Co., Milwaukee, WI) in 97:3 
DCM:DMF (both solvents from Aldrich Chemical Co., Milwaukee, WI) at room 
temperature for 12 hours. 
Adamantane-containing peptoids were synthesized in one of two ways.  First, by 
incorporating mono-trityl 1,4-diaminobutane, deprotecting it with 95:4:1 
water:triisopropylsilane:trifluoracetic acid (TIS, Aldrich Chemical Co., Milwaukee, WI), 
and coupling 1-adamantanecarboxylic acid (Aldrich Chemical Co., Milwaukee, WI) with 
4 equivalents of DIC.  Second, by coupling 1-adamantanecarboxylic acid with an excess 
of 2,2′-(ethylenedioxy)diethylamine (Aldrich Chemical Co., Milwaukee, WI) using  1-
Ethyl-3-(3-dimethyllaminopropyl)carbodiimide hydrochloride (EDC, Novabiochem, La 
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Jolla, CA) to form 1 (Fig. 2.4).  This adamantane-spacer-amine was then substituted into 















Figure 2.4: Schematic of how adamantane is incorporated into peptoids by 
first synthesizing (1). 
 
 Peptoid-DNA oligodeoxynucleotide (ODN) conjugates were synthesized first 
preparing N-iodoacetyl peptoids, as described in this work.  ODNs with 5′ C6 disulfide 
modifiers were prepared commercially (formerly, Beckman Institute Biopolymer 
Synthesis Facility, Pasadena CA, presently, Qiagen, Valencia, CA).  These were 
resuspended at 50 µM concentration in pH 7.2 100 mM NH4HCO3 (Aldrich Chemical 
Co., Milwaukee, WI) in DNase-free water (Gibco, via Invitrogen, Carlsbad, CA).  To 
this, a 20-fold excess of tris-carboxyethylphosphine (TCEP, Pierce Biotechnology, 
Rockford, IL) was added, and immediately followed by a 40-fold excess of N-iodoacetyl 
peptoid.  The mixture was placed under argon and gently mixed for 72 hours.  The 
product was purified using reverse phase HPLC over a Zorbax 300Extend-C18 column in 
an Agilent 1100 system.  The peaks were eluted with a linear gradient of 1-70% B in A 
over 50 minutes at 0.3 mL/min (solvent A=100 mM TEAA (Fluka, via Aldrich Chemical 




 2.2.3  Analytical Procedures 
 
 Analysis of peptoids was accomplished by reverse phase HPLC over a Zorbax 
300Extend-C18 column in an Agilent 1100 system.  The peaks were eluted with a linear 
gradient of 0-75% B in A over 50 minutes at 0.3 mL/min (solvent A=0.1% TFA in 100% 
water, solvent B=0.1% TFA  in 100% acetonitrile).  The column was held at 30 °C, and 
detection was accomplished by means of a diode array detector at 220 nm.   
Analysis of ODNs and peptoid-ODN conjugates was accomplished by reverse 
phase HPLC over a Zorbax 300Extend-C18 column in an Agilent 1100 system.  The 
peaks were eluted with a linear gradient of 1-70% B in A over 50 minutes at 0.3 mL/min 
(solvent A=100 mM TEAA in 100% water, solvent B=100mM TEAA in 90% 
acetonitrile, 10% water).  The column was held at 30 °C, and detection was accomplished 
by means of a diode array detector at 220 nm and 260 nm. 
Mass spectrometry of crude samples and HPLC fractions was accomplished by 
matrix-assisted laser desorption spectrometry with time-of-flight analysis (MALDI-TOF) 
on an Applied Biosystems Voyager-DE PRO BioSpectrometry Workstation firing a 337 
nm nitrogen laser.  Peptoids were generally analyzed with a matrix of α-cyano-4-
hydroxycinnaminic acid (Aldrich Chemical Co., Milwaukee, WI), formulated at 10 
mg/mL with 0.1% TFA in 50:50 water:acetonitrile.  ODNs and peptoid-ODN conjugates 
were generally analyzed with a matrix of 3-hydroxypicolinic acid (Aldrich Chemical Co., 
Milwaukee, WI), formulated at 5 mg/mL with 0.05 mg/mL dibasic ammonium carbonate 
(Aldrich Chemical Co., Milwaukee, WI) in 90:10 water:acetonitrile. 
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2.3  Results and Discussion 
 
2.3.1  Branched Peptoids 
 
The branched structures BR1, BR2, and BR3 (Fig. 2.5) were synthesized using 
the submonomer method with the primary amine sequence shown in Table 2.2. 
BR1 BR2 BR3 
Benzylamine Benzylamine Benzylamine 
Diaminobutane Benzylamine Benzylamine 
Benzylamine Diaminobutane Diaminobutane 
 Methoxyethylamine Methoxyethylamine 
 Methoxyethylamine Propylamine 
  Diaminobutane 
  Benzylamine 
  Methoxyethylamine 
Table 2.2: Primary amine submonomers used for syntheses of branched 
peptoids BR1, BR2, and BR3. Branches are introduced by diaminobutane incorporation. 
 
Following the incorporation of diaminobutane, the next bromoacetylation step 
creates a peptide bond that may not be desirable depending on the application.  
Successful synthesis of these example sequences is indicated by MALDI-TOF, (Fig. 2.6).  
RP-HPLC analysis indicated an average of 90% yield, as exemplified by the data shown 



















































































Figure 2.5: Schematic illustrations of three branched structures of increasing size.  
Synthesis methods are detailed in Table 2.2. 
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Figure 2.6: MALDI-TOF spectra of three branched structures of increasing 
size, BR1 (a), BR2 (b), and BR3 (c).  The masses of the three peptoids are visible as H+ 















 DAD1 A, Sig=220,8 Ref=500,100 (JOHN\ODDSL008.D)
 
Figure 2.7: RP-HPLC separation and detection at 220 nm of as-made 




2.3.2  Peptoid Capping 
 
Peptoid capping was demonstrated by synthesizing two peptoids (Fig. 2.8) using 









Table 2.3: Primary amine submonomers used for syntheses of capped 
peptoids CP1 and CP2. 
 
Three complete rounds of synthesis were executed after the addition of the 
capping secondary amine.  In the case of CP1, MALDI-TOF (Fig. 2.9) indicates that the 
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N,N-diethylamine largely blocks extension of the peptoid chain, where as in CP2, 






























Mol. Wt.: 487.59  









































































Figure 2.9: MALDI-TOF spectra of product of two attempts to cap the 
peptoid growing chain.  In (a), CP1 largely blocks chain extension, where as in (b), CP2 
fails to block chain extension.  The masses of the peptoids are visible as H+ adducts. 
 
2.3.3  N-terminal Modifications 
 
Normally, the final addition to the peptoid growing chain in the submonomer 
synthesis is a primary amine, leaving a secondary amine N-terminus.  In these six 
examples, Figure 4.10, the final step was an acetylation using one of the acids in Table 
2.4.  The calculated masses of these peptoids are evident in MALDI-TOF spectra (Fig. 
2.11).  The yields of these peptoids varied from at least 85% up to greater than 97% as 
measured by RP-HPLC, with a typical analysis shown in Figure 2.12. 
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Structure Code Final acetylation step submonomer 
NT1 Bromoacetic acid 
NT2 Iodoacetic acid 
NT3 Diglycolic acid 
NT4 Succinic acid 
NT5 Alanine 
NT6 γ-Aminobutyric acid 




































































































































 Figure 2.10: Schematic illustration of six peptoids with alternative N-termini. These 
were formed by terminating the growing peptoid chain with an acetylation step instead of 













































































































































































Figure 2.11: MALDI-TOF spectra of six N-terminal-modified peptoids, NT1-
NT6.    For NT1, (a), two groups of peaks represent the Na+ and K+ adducts, and 
incorporation of bromine accounts for the peak splitting within each of the two groups.  
For NT2, (b), NT3, (c), NT4, (d), and NT5 (e), the Na+ and K+ adducts are evident.  For 
NT6, (f), the H+ adduct is visible as well as the salt adducts.  
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 DAD1 A, Sig=220,8 Ref=500,100 (JOHN\ODDSL005.D)
 
Figure 2.12: RP-HPLC separation with detection at 220 nm of N-iodoacetyl 




2.3.4  Macrocyclic Peptoid 
 
Peptoid macrocyclization was demonstrated by first synthesizing a 
difunctionalized free-acid free-amine peptoid CY1 (Fig. 2.13) using the submonomer 
method with the primary amine sequence shown in Table 2.5.  The peptoid was 
terminated with diglycolic acid.  Following this, the peptoid was cyclized (Fig. 2.14), to 
form CY2.  The loss of water during the cyclization is evident in the MALDI-TOF, 
Figure 2.15.  The two species are difficult to separate using RP-HPLC, with retention 
times differing by less than 30 seconds in our methods.  The pre- and post-cyclization 
















Table 2.5: Primary amine submonomers used for syntheses of macrocyclic 





































































































































































Figure 2.13: Schematic illustrations of the synthesis of CY1 free-acid free-amine 
















































































Figure 2.14: Schematic illustration of cyclization of CY1 into CY2 using peptide 
coupling reagents PyBOP and DIPEA. 
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Figure 2.15: MALDI-TOF spectra of free-acid free-amine peptoid, CY1, (a), 
and the cyclized product, CY2, (b).  In (a), the H+ adduct is evident, while in (b), the 
H+, Na+ and K+ adducts are evident. 
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 DAD1 A, Sig=220,8 Ref=500,100 (JOHN\ODDSL006.D)
(a) 











 DAD1 A, Sig=220,8 Ref=500,100 (JOHN\ODDSL007.D)
(b) 
Figure 2.16: RP-HPLC separation with detection at 220 nm of pre- and post-
cyclization peptoids CY1 (a) and CY2 (b). 
 
2.3.5  Oligo-Adamantane Peptoids 
 
Two tetra-adamantyl peptoids (Fig. 2.17) were synthesized using the submonomer 
method with the primary amine sequence shown in Table 2.6.  AD2 required no 
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additional modifications after chain synthesis using 1, Figure 2.4, but AD1 required a 
deprotection step following by a peptide coupling step, Figure 2.18.   The calculated mass 
of AD2 is evident in MALDI-TOF spectra, Figure 2.19, but it may be that the synthesis 
of AD1 resulted in an unexpected outcome.  
 
AD1 (precursor) AD2 
1 Mono-trityl 1,4-diaminobutane 
Propylamine Propylamine 
1 Mono-trityl 1,4-diaminobutane 
Propylamine Propylamine 
Propylamine Mono-trityl 1,4-diaminobutane 
1 Propylamine 
Propylamine Mono-trityl 1,4-diaminobutane 
1  
Table 2.6: Primary amine submonomers used for syntheses of adamantyl-




















































































































































Figure 2.18: Schematic illustration of the process for deprotecting pendant amines 






























































Figure 2.19: MALDI-TOF spectra of tetra-adamantyl peptoids.  AD1, (a), is 
evidence by the H+ adduct.  In (b), the spectrum indicates H+ and Na+ adducts that are 
somewhat different from the theoretical mass of AD2. 
 
 
2.3.6  Oligodeoxynucleotide-Peptoid Conjugates 
 
The 5′-disulfide ODN IC1 was combined with an excess of TCEP, immediately 
followed by an excess of N-iodoacetyl peptoid in ammonium bicarbonate buffer, (Fig. 
2.20.  The three steps of the reaction are tracked with RP-HPLC (Fig. 2.21) and the 
predicted masses are confirmed by MALDI-TOF (Fig. 2.22).  The reaction generally 



































































MW = 6375.4 Da
IC2
MW = 6243.2 Da
IC3
MW = 6875.9 Da
 
Figure 2.20: Schematic illustration of process for conjugating N-iodoacetyl peptoids 


























































































































Figure 2.21: RP-HPLC separation and detection of commercially prepared 5′ 












































































Voyager Spec #1[BP = 6895.1, 11261]
6896.12
(c) 
Figure 2.22: MALDI-TOF spectra of commercially prepared 5′ disulfide 
ODN IC1, (a), TCEP-reduced ODN IC2, (b), and peptoid-ODN conjugate IC3, (c).
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2.4  Summary 
 
This work has demonstrated several new methodologies that can expand the range 
of applications for peptoids.  I show that (i) branched peptoids can be synthesized by 
incorporating an unprotected diamine submonomer, (ii) that N,N-diethylamine can 
effectively cap the peptoid growing chain, (iii) that six N-terminal modifications for 
peptoids, including two haloacetamides, two acids, and two amines can be prepared, (iv) 
that peptoids can be macrocyclized by incorporating a C-terminus-proximal pendant 
amine, terminating the growing chain with an acid, and using peptide coupling reagents 
to complete the cyclization, (v) that adamantane can be incorporated into peptoids by 
including short spacers between the main peptoid chain and the pendant adamantyl 
moiety, and (vi) that peptoid-oligodeoxynucleotide conjugates can be produced in high 
yield by combining N-terminal iodoacetyl peptoids and 5′ thiol ODNs. 
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3.1  Introduction 
 
 The mass-spectrometric analysis of gene expression (MAGE) methodology is 
designed to unambiguously quantify one or more nucleic acids simultaneously in 
multiple samples, using mass spectrometry for the means of ultimate detection.  An assay 
that makes use of mass spectrometry is desirable because in recent years mass 
spectrometer sensitivity has reached the zeptomolar region and below, and dynamic 
ranges in excess of six orders of magnitude; these capabilities could relax the dynamic 
range restrictions and decrease nucleic acid material requirements inherent in current 
methods for studying gene expression. MALDI-TOF has been demonstrated to detect as 
little as 2 attomoles of peptides near 1000 Da in the standard format, and as little as 42 
zeptomoles in a microspot format 1.  It is theorized that MALDI-TOF systems and 
MALDI-TOF/TOF systems are capable of even greater sensitivity, but the field is 
currently limited by a poor understanding of the origin of noise present in all MALDI-
TOF spectra 2.  Isotopic dilution has been demonstrated to function over 4 orders of 
magnitude in MALDI-TOF systems 3,4. Further, MAGE relies on solution-phase 
hybridization for target recognition, a practice thought to contribute to the greater 
reliability of many single-transcript methods (e.g., real-time PCR) as compared to high-
throughput methods (e.g., cDNA microarrays). 
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 Mass spectrometry alone cannot be used to quantify specific sequences in a 
mixture of nucleic acids.  This is not only because many different sequences can share the 
exact same mass, but also because many constitutively different nucleic acids can have 
nearly identical masses.  Furthermore, the detection of nucleic acids becomes 
increasingly difficult as their masses increase5, and lastly, even if a particular sequence 
could be identified in a mixture, it would not be straightforward to determine its molar 
abundance.  MAGE establishes a one-to-one relationship between nucleic acid sequences 
of interest and small, inert tag molecules that can be distinguished and quantified using 
mass spectrometry.   The MAGE methodology is outlined in Figure 3.1, and involves the 
following five steps: (1) Add probe molecules to unknown cDNA mixture and allow 
them to hybridize; (2) Ligate hybridized ODNs; (3) Separate Biotin-ODNs from mixture; 
(4) Cleave peptoid tags from ODNs and recover peptoids; (5) Add "heavy" peptoids as 
internal standards and perform mass spectrometry. 
The MAGE methodology can be viewed as a version of a ligase detection 
reaction6,7 where the ligation step serves to covalently attach two entities, biotin and a 
peptoid, when the target SOI has been successfully detected.  By making use of a 
thermostable ligase, the detection phase of MAGE (steps 1 and 2) can be executed close 
to the melting temperature of the probes and target, thus minimizing spurious detection 











Unknown cDNA mixture, sequences 1,2 and 







Molar excess of ODNs complimentary to sequences 1 and 3 
conjugated via photocleavable linker to peptoids of masses 700 and


























Relative peak sizes indicate that two 
molecules of the cDNA 
complementary to the ODN 
conjugated to Pep700 were present 








Step 1: Solution hybridization of probe molecules to unknown cDNA mixture
Step 2: Ligate hybridized ODNs
Step 3: Separate Biotin-ODNs from mixture
Step 4: Cleave Peptoid Tags from ODNs and Recover
+
Step 5: Add "Heavy" Peptoids as Internal 




































Figure 3.1: The MAGE methodology. The method uses a ligation step to create 
molecules with both peptoid mass tag and biotin moieties in one-to-one proportion with 
sequences of interest.  The peptoids are subsequently cleaved, and quantified using 
isotopic dilution mass spectrometry. 
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The engineering of the ODN-mass tag conjugates is central to MAGE.  The inert 
tags must be chemically compatible with all of the assay steps, they must facilitate 
quantification, and they must be available in a wide variety of masses.  I chose N-
substituted glycine oligomers, or peptoids, to serve as mass tags.  Peptoids are 
synthesized by solid-phase methods with a simple submonomer chemistry, where 
alternating submonomers are primary amines8.  Because there are hundreds of suitable, 
commercially available amines, a large variety of oligomers can be synthesized.  They 
can be produced on an individual basis either manually or in a modified peptide 
synthesizer, or they can be produced in parallel using a mix-and-split method.  Peptoids 
are stable under a variety of thermal, chemical, and biological stresses; for instance, they 
are not subject to proteolytic degradation.  Furthermore, since they are nonnatural, it will 
be easier to distinguish them from any contaminating cellular components that might be 
in the target mixture of nucleic acids.  The peptoids are chosen to represent a suitable 
distribution of masses, and they can be designed to offer other properties, such as a 
chromatographic property set useful for the separation stages of MAGE.  Generally, 
submonomer amines are selected that yield water-soluble, non-cationic peptoids, such as 
methoxyethylamine and glycine. The peptoids, which are produced typically in greater 
than 95% yield and purity, can be purified further using HPLC methods similar to those 
used to purify peptides.  Further details on peptoid synthesis can be found in Chapter 2 of 
this thesis. 
 Once the peptoid tags are constructed, they are conjugated to DNA 
oligonucleotides of length 20 to 50.  A synthetic method was developed that allows 
functionalization of the N-terminus of the peptoid that is stable to cleavage from the 
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peptoid synthesis resin.  Using this method, peptoids with N-terminal iodoacetyl groups 
are produced.  The oligonucleotide is commercially produced with a 5′ disulfide modifier.  
Once reduced, the 5′ sulfhydryl oligonucleotide reacts with the N-iodoacetyl peptoid to 
form a thioether bond. 
Though thioether bonds are not reversible within the conditions used for MAGE, I 
used a commercially available phosphoramidite that contains a photolabile 
orthonitrobenzyl group.  This bond is stable to acid and base, but cleaves quantitatively 
when exposed to long-wave UV light for 5 minutes9-13.  This phosphoramidite is added to 
the 5′ end of the complete oligonucleotide, and is followed by the 5′ disulfide.  Then, 
when the conjugate is formed, the photocleavable bond is later be used to separate the 
DNA portion of the conjugate probe from the mass tag (step 4). 
The last major challenge is quantifying a mixture of dilute oligomeric species of 
unique mass using mass spectrometry (step 5).  For this, I made use of isotopic internal 
standards.  Isotopic dilution is not only convenient for MAGE, but it has also been shown 
theoretically to be the most accurate and sensitive method of mass spectrometric 
calibration4.  It has also been demonstrated for use in proteomics studies14-17.  For each 
peptoid mass tag in our detector library, we make a chemically identical species that has 
an isotopic shift by using D3 bromoacetic acid as a replacement submonomer during 
peptoid synthesis.  Each time the deuterated species is substituted, 2 Da are added to the 
molecular weight of the peptoid (the third deuterium is lost).  This can be repeated 
several times to separate the "heavy" peptoid from its isotopic standard in the mass 
dimension. Because the tags are chemically identical, they will ionize to almost exactly 
the same extent, and they will emerge from a chromatographic pre-separation at nearly 
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the same time.  The ratio of the peak sizes of the two species is used to determine their 
relative quantity.  This could be used to determine exact concentrations, or, by 
hybridizing the two libraries of probes to two different samples, the relative amounts of 
the target species in the two samples could be determined. 
To summarize, the method requires that at least one pair of ODN-cleavable 
linker-peptoid conjugates be created for each sequence of interest. These probes, along 
with 3′ adjacent biotin-labeled ODNs of equal length, are used to interrogate a target 
mixture of cDNA (step 1).  Following hybridization, the two adjacent probes are ligated 
to enhance the specificity of the identification (step 2), and to enable the use of a biotin-
affinity column for removal of non-hybridized peptoid tags (step 3).  The resulting 
mixture is exposed to longwave ultraviolet light to release the peptoid tags (step 4), 
which are quantified using MALDI-TOF mass spectrometry using the isotopically 




3.2  Experimental 
 
 3.2.1  Oligodeoxynucleotide Probes 
 
 Oligodeoxynucleotides (ODNs) with 3′ BiotinTEG modifiers and 5′ chemical 
phosphorylation were prepared commercially (formerly, Beckman Institute Biopolymer 
Synthesis Facility, Pasadena CA, presently, Qiagen, Valencia, CA).  Peptoids were 
synthesized using the method of Figliozzi et al.8, as detailed in Chapter 2 of this thesis.  
For MAGE, peptoid 5-mers synthesized uniformly of methoxyethylamine submonomers 
(Aldrich Chemical Co., Milwaukee WI) were terminated by a final acetylation with N-
iodoacetic acid (Fluka, via Aldrich Chemical Co., Milwaukee WI).  Isotopically modified 
peptoids were produced by repeated incorporation of D3-bromoacetic acid (Cambridge 
Isotopes, Andover MA). 
ODNs with three consecutive 5′ modifiers were prepared commercially (formerly, 
Beckman Institute Biopolymer Synthesis Facility, Pasadena CA, presently, Qiagen, 
Valencia, CA).  From 3′ to 5′, the modifiers (Glen Research Corp., Sterling VA) were 
Dabcyl-dT, PC-spacer, and C6-Disulfide.  These were resuspended at 50 µM 
concentration in pH 7.2 100 mM NH4HCO3 (Aldrich Chemical Co., Milwaukee, WI) in 
DNase-free water (Gibco, via Invitrogen, Carlsbad, CA).  To this, a 20-fold excess of 
tris-carboxyethylphosphine (TCEP, Pierce Biotechnology, Rockford, IL) was added, and 
immediately followed by a 40-fold excess of N-iodoacetyl peptoid.  The mixture was 
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placed under argon and gently mixed for 72 hours.  The product was purified using 
reverse phase HPLC over a Zorbax 300Extend-C18 column in an Agilent 1100 system.  
The peaks were eluted with a linear gradient of 1-70% B in A over 50 minutes at 0.3 
mL/min (solvent A=100 mM TEAA (Fluka, via Aldrich Chemical Co., Milwaukee, WI) 
in 100% water, solvent B=100 mM TEAA in 90% acetonitrile, 10% water). 
 
 3.2.2  MAGE Methodology 
 
 Target DNA was suspended in 1x ligation buffer for T4 DNA ligase, 66 mM Tris-
HCl, 5 mM MgCl2, 1 mM dithioerythritol, 1 mM ATP, pH 7.5 (Roche Applied Science, 
Indianapolis, IN).  To this, an-approximately 2-fold excess of 5′-peptoid and 3′-biotin 
probes were added and vortexed briefly.  The mixtures were then annealed by heating to 
94°C and gradually cooling to room temperature, at which time T4 DNA ligase was 
added at approximately 1 unit of ligase per 7 pmol of final product.  The mixture was 
ligated at 16°C for at least 12 hours.  Following this, Neutravidin (Pierce Biotechnology, 
Rockford IL) resin was added in approximately 4-fold excess to biotin probes and gently 
mixed for at least 3 hours.  The resulting suspensions were filtered using 0.22 µm 
Ultrafree-MC centrifugal filters (Millipore, Billerica, MA) and the resin washed several 
times each with phosphate buffered saline (Gibco, via Invitrogen, Carlsbad, CA),  
followed by NH4HCO3, 100 mM pH 8.2 (Aldrich Chemical Co., Milwaukee WI), 
followed by DNase-free water  (Gibco, via Invitrogen, Carlsbad, CA).  The resin is then 
resuspended in DNase-free water and exposed while stirring to longwave UV light from a 
B-100AP lamp (UVP Inc., Upland CA) for 20 minutes.  Following this, the solution is 
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removed from the resin using 0.22 µm Ultrafree-MC centrifugal filters, and the resin is 
washed twice with DNase-free water.  The filtrates are pooled and concentrated by 
lyophilization, then analyzed by MALDI-TOF mass spectrometry. 
 
 3.2.3  Analytical Procedures 
 
Analysis of peptoids was accomplished by reverse phase HPLC over a Zorbax 
300Extend-C18 column in an Agilent 1100 system.  The peaks were eluted with a linear 
gradient of 0-75% B in A over 50 minutes at 0.3 mL/min (solvent A=0.1% TFA in 100% 
water, solvent B=0.1% TFA  in 100% acetonitrile).  The column was held at 30° C, and 
detection was accomplished by means of a diode array detector at 220 nm.   
Analysis of ODNs and peptoid-ODN conjugates was achieved by reverse phase 
HPLC over a Zorbax 300Extend-C18 column in an Agilent 1100 system.  The peaks 
were eluted with a linear gradient of 1-70% B in A over 50 minutes at 0.3 mL/min 
(solvent A=100mM TEAA in 100% water, solvent B=100mM TEAA in 90% acetonitrile, 
10% water).  The column was held at 30° C, and detection was accomplished by means 
of a diode array detector at 220 nm, 260 nm and 450 nm. 
Mass spectrometry of crude samples and HPLC fractions was accomplished by 
matrix-assisted laser desorption spectrometry with time-of-flight analysis (MALDI-TOF) 
on an Applied Biosystems Voyager-DE PRO BioSpectrometry Workstation firing a 337 
nm nitrogen laser.  Peptoids were generally analyzed with a matrix of α-cyano-4-
hydroxycinnaminic acid (Aldrich Chemical Co., Milwaukee, WI), formulated at 10 
mg/mL with 0.1% TFA in 50:50 water:acetonitrile.  ODNs and peptoid-ODN conjugates 
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were generally analyzed with a matrix of 3-hydroxypicolinic acid (Aldrich Chemical Co., 
Milwaukee, WI), formulated at 5 mg/mL with 0.05 mg/mL dibasic ammonium carbonate 
(Aldrich Chemical Co., Milwaukee, WI) in 90:10 water:acetonitrile. 
 
3.3  Results and Discussion 
 
 3.3.1  Oligodeoxynucleotide Probes 
 
 In order to demonstrate the synthesis and subsequent cleavage of a peptoid-ODN 
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 Figure 3.2: Schematic illustrated of the preparation of conjugate PC3.  The peptoid-
ODN conjugate PC3 is synthesized by first reducing the 5′ disulfide of PC1 and then 
conjugating an N-iodoacetyl peptoid to PC2. 
 
The dabcyl label immediately 5′ of the main sequence of PC1 is a strongly absorbing 
chromophore at 450 nm, and it serves in this system to facilitate the tracking and 
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purification of the peptoid fragments using RP-HPLC.  The conjugation reaction 
proceeded to approximately 50% yield as indicated by RP-HPLC (Fig. 3.3) which was 
unusually low relative to tests without the dabcyl label. 
Figure 3.3: RP-HPLC chromatogram of crude PC3 product.  RP-HPLC separation 
with detection at 260 nm of the crude PC3 product indicates approximately 50% yield.  
The conjugate PC3 elutes earlier than the starting material PC1. 
 
RP-HPLC was used to separate the desired product from the starting material, and 
MALDI-TOF mass spectrometry confirmed the expected masses of the two species, (Fig. 
3.4).  Because the MALDI-TOF fires a 337 nm laser, the two species were visible in 
MALDI-TOF spectra in both their full-length and fragmented states (Fig. 3.5 and Fig. 
3.6). 










 DAD1 B, Sig=260,8 Ref=700,50 (JOHN\IS36CR.D)
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 72





























10748.647946.23 8486.216902.026248.70 10780.386621.94 9306.44 10466.458451.706273.33 8114.697023.66 9331.507774.367385.59 10861.1310553.796667.966126.93 8352.45 10065.017122.446386.59 7811.69 8904.69 9410.469166.516051.58 11205.358062.947398.37 10899.966493.44 6874.76 10408.328462.997724.40 9645.439259.647239.56 11600.328164.74 8884.566406.08 7741.92
(a) 


































11369.219416.026244.01 10873.699164.997643.286504.70 11485.646168.27 9544.92 10852.397046.23 10499.686296.66 9178.21 11650.596662.42 9651.017442.157120.40
(b) 
Figure 3.4: MALDI-TOF analysis of the two main peaks of the RP-HPLC 
separation of crude PC3.  For each fraction, two MALDI-TOF peaks were detected 
because the photocleavable bond is fragmented by the MALDI laser.  The masses of the 
two main peaks agreed with the expected products of (a), Figure 3.4, and (b), Figure 3.5.  
The smaller peaks in (a) and (b) are identical because only the 5′ side of the PC1 material 



























































































































Figure 3.5: Schematic illustration of how exposure to longwave UV light by a lamp 






























































































Figure 3.6: Schematic illustration of how exposure to longwave UV light by a lamp 





 Following purification (Fig. 3.7(a)) the PC3 conjugate was intentionally cleaved 
by 10 minutes of exposure to longwave UV light, and the resulting mixture was analyzed 
by RP-HPLC (Fig. 3.7(b)).  The large DNA fragment, PC5, was detected at 260 nm, 
while the smaller peptoid fragment, PC4, was detected at 450 nm.  The peptoid fragment 
was visible in a number of smaller peaks, possibly due to rearrangement during the 
photocleavage.  The calculated area under the several peaks shown in Figure 3.7(b, 
bottom) is within 95% of the area under the single peak shown in Figure 3.7(a, bottom).  
The expected masses of PC4 and PC5 are observed when they are collected by RP-HPLC 
and analyzed by MALDI-TOF (Fig. 3.8). 
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Figure 3.7: RP-HPLC chromatogram of cleavage process.  The purified PC3 peptoid-
ODN conjugate was analyzed by RP-HPLC with detection at 260 nm (a, top) and 450 nm 
(a, bottom).  Exposure to longwave UV light resulted in cleavage of PC3 into PC4 and 
PC5.  The DNA fragment PC5 post cleavage is visible at 260 nm (b, top), while the 






























































Figure 3.8: MALDI-TOF analyses of cleavage process.  After exposure to longwave 
UV light, the cleavage products of PC3 were collected and analyzed by MALDI-TOF.  
The fragment visible in 260 nm (a) had a mass that agreed with PC5, and the fragment 
visible in 450 nm (b) had a mass that agreed with PC4. 
 
 3.3.2  Mass-Spectrometric Quantification 
 
 Two 5-mer uniform methoxyethylamine peptoids were synthesized to 
demonstrate quantification using isotopic dilution MALDI-TOF (Fig. 3.9).  Following 
post-synthetic lyophilization, the two peptoids were dissolved in water at equal molar 
concentrations, and combined at specific volumetric fractions.  The resulting mixtures 
were analyzed by MALDI-TOF, and three spectra were recorded for each mixture.  
Because of naturally occurring 13C isotopes, as well as hydrogen incorporation into ID2 
due to impurities in D3-bromoacetic acid, it was necessary to calculate the area under a 
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curve spanning several Dalton (Fig. 3.10).  The ratios of the areas corresponding to ID1 
and ID2 were calculated and compared to the volumetrically measured mole fractions 
(Fig. 3.11 and Table 3.1).  An example spectra for a 1:1 mixture of the two peptoids ID1 
and ID2 (Fig. 3.9).    The method was tested over 5 orders of magnitude.  It is observed 
that the method functions optimally within 2.  This is due to a combination of noise from 
impurities in the peptoid solutions as well as noise inherent to the MALDI process.  A 
useful feature of isotopic dilution is that the amount of standard can be adjusted so that 

























































































C, 50.66; H, 8.16; N, 14.18; O, 26.99
 
Figure 3.9: Schematic illustrations of ID1 and ID2 syntheses.  Isotopically-shifted 
“heavy” peptoids such as ID2 are synthesized by incorporating D3-bromoacetic acid. 
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Figure 3.11: Measured mole fractions compared to predicted mole fractions.  
Peptoid ID1 and 10-fold deuterated peptoid ID2 were mixed in various proportions, and 
analyzed by MALDI-TOF.  The areas under the curves respective to each peptoid were 
used to estimate the relative mole fractions and compare those estimates to the 




Volumetric   MALDI-TOF Prediction Volumetric   MALDI-TOF Prediction 
ID1 ID2 ID1 ID2 ID1 ID2 ID1 ID2 
0.001 0.999 0.005 0.995 0.500 0.500 0.505 0.495 
0.001 0.999 0.004 0.996 0.500 0.500 0.501 0.499 
0.005 0.995 0.009 0.991 0.600 0.400 0.603 0.397 
0.005 0.995 0.008 0.992 0.600 0.400 0.644 0.356 
0.010 0.990 0.016 0.984 0.700 0.300 0.696 0.304 
0.010 0.990 0.014 0.986 0.700 0.300 0.681 0.319 
0.010 0.990 0.050 0.950 0.750 0.250 0.665 0.335 
0.010 0.990 0.060 0.940 0.750 0.250 0.639 0.361 
0.010 0.990 0.026 0.974 0.800 0.200 0.764 0.236 
0.050 0.950 0.062 0.938 0.800 0.200 0.737 0.263 
0.050 0.950 0.053 0.947 0.900 0.100 0.841 0.159 
0.100 0.900 0.074 0.926 0.900 0.100 0.863 0.137 
0.100 0.900 0.082 0.918 0.900 0.100 0.874 0.126 
0.100 0.900 0.178 0.822 0.900 0.100 0.785 0.215 
0.100 0.900 0.115 0.885 0.900 0.100 0.876 0.124 
0.100 0.900 0.134 0.866 0.950 0.050 0.933 0.067 
0.200 0.800 0.197 0.803 0.950 0.050 0.922 0.078 
0.200 0.800 0.229 0.771 0.990 0.010 0.980 0.020 
0.250 0.750 0.340 0.660 0.990 0.010 0.984 0.016 
0.250 0.750 0.223 0.777 0.990 0.010 0.978 0.022 
0.300 0.700 0.281 0.719 0.990 0.010 0.946 0.054 
0.300 0.700 0.293 0.707 0.990 0.010 0.984 0.016 
0.400 0.600 0.438 0.562 0.995 0.005 0.986 0.014 
0.400 0.600 0.400 0.600 0.995 0.005 0.982 0.018 
0.500 0.500 0.501 0.499 0.999 0.001 0.973 0.027 
0.500 0.500 0.472 0.528 0.999 0.001 0.982 0.018 
Table 3.1: Measured mole fractions compared to predicted mole fractions. Peptoid 
ID1 and 10-fold deuterated peptoid ID2 were mixed in various proportions, and analyzed 
by MALDI-TOF.  The areas under the curves respective to each peptoid were used to 
estimate the relative mole fractions and compare those estimates to the volumetrically 
measured mole fractions. 
 
 
 3.3.3  MAGE Methodology 
 
In order to test that the MAGE methodology can discriminate targeted sequences 
from incorrect sequences, four target mixtures were analyzed for a 60mer sequence from 
mouse muscle cells:  
 80
(A) 0.5 nmol 60-mer ODN of antisense myogenin 
(B) 1.0 pmol APETALA cDNA 
(C) 1.0 pmol each APETALA and Myogenin "full length" cDNA 
(D) 1.0 pmol Myogenin "full length" cDNA 
Here, cDNAs were random-primed first-strand syntheses of clones from mouse 
C2C12 tissue culture (Myogenin) or Arabadopsis thaliana (APETALA).  Target A 
represents a high-concentration positive control, target D represents a negative control, 
and targets B and C are intermediate points.   The sequence of target A is: 5′ AAA CAC 
ACA ACA AAC ATT TCG ACG GCG GAC TGG TTC CAG AGG ACA CGA CTA 
CTA TGG CCC 3′. 
 To interrogate these targets, the probes M1 and M2 were prepared (Fig. 3.12).  
M2 is a 30-mer ODN that is 5′ phosphorylated and immediately 3′ of the 30-mer ODN 
M1.  The combined 60-mer sequence is exactly complementary to the ODN target A, and 
is also complementary to sequences found within the majority of the random-primed 
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Figure 3.12: Probes M1 and M2.  Probe M1 is a 30-mer ODN 5′ reversibly conjugated 
to a peptoid. Probe M2 is a 30-mer ODN that is 5′ phosphorylated and 3′ biotinylated.  




 The MAGE assay was executed on each sample.  After the photocleavage stage, 
those target mixtures where M1 and M2 were ligated (indicating a successful detection 
event) should contain the peptoid fragment M1P (Fig. 3.13).   At the quantification stage, 









































































Figure 3.13: Release of M1P tag.  During MAGE, the successfully ligated M1-M2 
probes are captured by Neutravidin resin.  The peptoid fragments M1P are freed by 
exposure to longwave UV light. 
 
 MALDI-TOF mass spectrometry showed the presence of the expected peptoid 
fragment MP1 only in target mixture A, the higher-concentration ODN target (Fig. 
3.14(a)).  In the other mixtures, no signal was detected (Fig. 3.14(b)). 
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Voyager Spec #1=>BC[BP = 552.2, 28463]
(b) 
Figure 3.14: MALDI-TOF analysis of M1P tag.  The MAGE methodology was 
employed to detect a 60-nucleotide segment of the myogenin gene in four mixtures.  
Mixture A contained 500 pmols of a synthetic ODN myogenin target, Mixtures B and C 
contained 1 pmol of myogenin cDNA, and mixture D contained only cDNA from the 
APETELA gene.  MAGE detected the target in mixture A, (a), but did not in mixtures B, 
C or D (representative spectrum, b). 
 
 
A second test of the MAGE methodology employed six target mixtures of two 
synthetic 60-mer anti-sense ODNs, T1 and T2;  T1 is from mouse myogenin, T2 is from 
mouse paraoxonase.  The six mixtures combine the two ODNs in various proportions as 
shown in Table 3.2. 
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 pmols T1 pmols T2 
A 250 0 
B 125 125 
C 25 225 
D 2.5 247.5 
E 0.25 249.75 
F 0 250 
Table 3.2: Relative amounts of T1 and T2 in targets.  The targets for experiment 2 are 
mixtures of anti-sense oligonucleotides representing mouse myogenin and mouse 
paraoxonase in various proportions. 
 
The sequence of the T1 target is: 5′ AAA CAC ACA ACA AAC ATT TCG ACG 
GCG GAC TGG TTC CAG AGG ACA CGA CTA CTA TGG CCC 3′, while the 
sequence of the T2 target is: 5′ CCG TGA CAC AAG GTG TTT CGA GAA ATG ACA 
CTA GAC ACT GTT CGG TCG ACG TGC GTG CAG 3′. 
 To interrogate these targets, the probes M3 and M4 were prepared (Fig. 3.15).  
M3 is a 30-mer ODN that is 5′ phosphorylated and immediately 3′ of the 30-mer ODN 
M4.  The combined 60-mer sequence is exactly complementary to the ODN target T1, 
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Figure 3.15: Probes M3 and M4. Probe M3 is a 30-mer ODN 5′ reversibly conjugated 
to a peptoid. Probe M4 is a 30-mer ODN that is 5′ phosphorylated and 3′ biotinylated.  
When arranged 5′ M3 M4 3′, they form a 60-mer probe for the mouse gene Myogenin. 
 
The MAGE assay was executed on each sample.  After the photocleavage stage, 
those target mixtures where M3 and M4 were ligated (indicating a successful detection 
event) should contain the peptoid fragment M3P (Fig. 3.16).   At the quantification stage, 



























































































































Figure 3.16: Release of M3P tag. During MAGE, the successfully ligated M1-M2 
probes are captured by Neutravidin resin.  The peptoid fragments M1P are freed by 
exposure to longwave UV light. 
 
MALDI-TOF mass spectrometry showed the presence of the expected peptoid 
fragment MP3 in mixtures A, B, C, D, and E (Fig. 3.14(a-e)).  In the negative control, 
mixture F, the peptoid MP3 was not detected, (Fig. 3.14(f)).  During the course of the 
MALDI-TOF analysis, the settings of the spectrometer were altered to obtain the best 
possible signal for each sample.  Thus, the relative peak sizes in Figures 3.14(a-e) are not 
indicative of the abundances of T1.  Furthermore, since the kinetics of hybridization 
between the probes and targets used in this experiment were not studied independently, 
and the hybridization conditions were fixed across mixtures A-F, it is not possible to 
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Voyager Spec #1[BP = 1056.6, 10470]
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Figure 3.17: MALDI-TOF Detection of M3P tags. The MAGE methodology was 
employed to detect a 60-nucleotide anti-sense ODN of the myogenin gene in six 
mixtures.  Each mixture contains 250 pmols of ODN.  Mixture A contains entirely T1, 
mixture F contains entirely T2, and B-E are intermediate amounts listed in Table 3.3.  
The correct expected mass of the peptoid fragment MP3 was detected in samples A-E (a-
e), but not clearly in F (f). 
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3.4  Summary 
 
 A methodology for measuring the absolute abundances of specific nucleic acid 
sequences by means of mass spectrometry has been developed.  The method involves 5 
steps: (1) add probe molecules to unknown cDNA mixture and allow them to hybridize; 
(2) ligate hybridized ODNs; (3) separate Biotin-ODNs from mixture; (4) cleave peptoid 
tags from ODNs and recover peptoids; (5) add "heavy" peptoids as internal standards and 
perform mass spectrometry. 
 The chemistry of the reversible peptoid mass tag-ODN probes has been 
demonstrated in detail using a dabcyl label to facilitate RP-HPLC purification of the 
photocleavage fragments.  The effectiveness of isotopic dilution for quantitative MALDI-
TOF has been demonstrated over several orders of magnitude.  Finally, the complete 
MAGE methodology has been executed on two sets of target mixtures.  The results show 
that MAGE may be capable of discriminating correct sequences from incorrect 
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 In their most general form, gene expression data are one or more measurements of 
the extent to which one or more genes of interest are being transcribed in a sample of 
tissue or cells.  In simpler examples of gene expression analysis, such as Northern blots1, 
one or several genes are studied at one or several conditions.  In these cases, sufficient 
analysis comprises simple estimations of confidence intervals2.  Recently, techniques 
such as hybridization-based microarrays have been developed that can simultaneously 
measure the expression levels of thousands of genes of interest3,4.  Data such as these are 
not easily visualized in a helpful way, and significant analysis presents a further 
challenge.  Once the data have been cursorily screened for genes of exceptional interest 
or outlying points, investigators must turn to more sophisticated techniques for locating 
statistically significant information within their data. 
 The unit of gene expression data presented for analysis is a matrix described by 
several features.   Each element of the matrix is the value assigned the expression of a 
particular gene in a particular condition.  The matrix can be viewed as a set of column 
vectors, with each vector carrying either the data for one gene at all conditions of interest, 
or the data for all genes of interest at one condition.  In the first case, the gene vectors 
exist in a potentially reducible condition space of a number of dimensions equal to the 
number of conditions of interest.  In the second case, the condition vectors exist in the 
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potentially reducible gene space where the number of dimensions is equal to the number 
of genes of interest.  The actual value stored at a given location in the matrix could 
describe the gene expression in a variety of ways.  Most commonly, the value is a 
positive function of the number of mRNA transcripts of the gene of interest found in a 
sample of tissue or cells at the condition of interest5.  The nature of this function is a 
combination of the choice of gene expression data-collection method and the 
preprocessing steps that are applied to the raw data.  Often, the contribution to this 
function from the controlling physics of the method of choice is unknown6. 
 Several pioneering studies of large-scale gene expression analysis generated data 
describing the expression of several thousands of genes over 5 to 100 conditions7-9.  In 
some of these studies, the investigators examined the relative locations of the gene 
vectors in condition space.  An example of this was the study by Chu et al. of the 
transcriptional program of sporulation in budding yeast7, which sought to identify related 
or coexpressed genes, and hypothesized that such genes would be represented by gene 
vectors somehow close to one another in condition-dimensional space.  It remains a 
subject of great interest how best to define close, and how best to determine statistically 
significant groups of close genes.  In other studies, the investigators examined the relative 
locations of the condition vectors in gene space.  An example of this was the study by 
Sorlie et al. of human breast tumors9,10, which hoped to correlate some reduction of the 
gene expression data with the outcome of the diseased patient, and hypothesized that the 
condition vectors associated with tumors from patients with similar outcomes would be 
similarly close to one another in gene-dimensional space.   
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A significant and currently unavoidable challenge of large-scale gene expression 
analysis is that because thousands of genes are simultaneously analyzed, and each 
experiment represents a significant cost, the matrix of data presented for analysis will be 
highly rectangular; the genes dimension will be much larger than the conditions 
dimension11.  In the Chu et al. example, the space for analysis is extremely rich, and 
highly unlikely to be degenerate.  The Sorlie et al. example, and those like it12,13, on the 
other hand, presents a very sparsely populated space.  It is far more difficult to analyze 
the Sorlie space using robust techniques of linear algebra and multivariate statistical 
inference, not only because the vectors fail to fully define the space, but also because so 
many analytical techniques suffer from what is known as the curse of dimensionality14.  
The curse is a catch-all term for problems arising from the fact that the volume, and 
computational complexity, of a space grows exponentially with the number of 
dimensions. 
Two important goals of an analysis like those employed in the canonical studies 
discussed above are to produce intelligible visual representations of the high-dimensional 
data, and to develop and apply algorithms capable of identifying significant correlations 
in the data that investigators could not easily notice without this aid.  These algorithms 
might be designed to search the data for correlations that support a predetermined 
hypothesis, or they might be designed to find unspecified correlations that might aid the 
investigator in creating testable hypotheses.  The most common type of analysis applied 
to gene expression data is some form of clustering algorithm designed to identify subsets 
of data that are similar. 
Visualization Strategies 
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By far the most common visualization strategy for gene expression data is to 
simply depict the relevant portion of the data matrix with each element colored to 
represent the value of the element7,9,15-17.  This method has the main advantages of being 
easily implemented and spatially compact; it is a simple task to locate data of interest.  
However it does not offer what many modern multivariate data visualization techniques 
offer, which is either some mathematical consistency, such as projection onto orthogonal 
basis functions18, or a representation that is especially suited for analysis by the human 
brain, such as Chernoff faces19,20. 
Andrews proposed to plot multivariate data in two dimensions by mapping the 
data vectors onto a simple trigonometric polynomial basis function21.  If each vector is 
represented as ),...,(~ 1 nvvv = , where n is the number of dimensions, then the Andrews plot 
of the vector is generated by the function 
...)2cos()2sin()cos()sin(
2
)( 54321 +++++= tvtvtvtv
vtFv    (Eq. 4.1) 
over the domain )( ππ <<− t . 
Andrews curves allow multiple points of multivariate data to be plotted in a single 
two dimensional space simultaneously, and allow clusters to be visually distinguished.  
The reason for this clustering behavior is that Andrews curves, like all orthogonal basis 
functions, preserve the means, distances, and variances of untransformed data.  In 
particular, the Euclidian distance between any two vectors is proportional to a 
straightforward view of the distance between two corresponding transformed functions. 





22 )()(~~       (Eq. 4.2) 
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Andrews curves have been applied to data of biological interest such as pharmaceutical 
formulation data22 and psychiatric data23, and they have been generalized with wavelet 
theory18.  Here, I present the application of Andrews curves to the Chu et al. data set and 
the Sorlie et al. data set. 
Data Reduction Strategies: Principal Components Analysis 
 Even though Andrews curves can map vectors of any length to two-dimensional 
space, they generally lose meaning as the number of dimensions increase; the curves 
become confusing rather than elucidating21.  Further, since the first, low frequency, terms 
in the Fourier series have the most influence on the visual appearance of the plot, some 
preprocessing of the data is helpful.  Andrews and others24 suggest that the data be 
subjected to a deterministic data reduction strategy such as principal components analysis 
(PCA) in order to both reduce the number of dimensions and to sort the dimensions in 
order of importance.  In algorithmic terms, PCA identifies the direction of greatest 
variance in a set of vectors, ranks this as the first eigenvector, and then proceeds to 
iteratively identify the direction of next-greatest variance that is orthogonal to all those 
eigenvectors previously identified.  The algorithm can be terminated by design, if only a 
small number of eigenvectors account for a satisfactory fraction of the variance, or it is 
terminated by necessity when the number of eigenvectors reaches whichever is smaller, 
either the number of vectors, or the length of the vectors.   
PCA has been successfully applied to gene expression data to differentiate 
between eigenvectors associated with artifacts, noise, and biological processes25-27.  PCA 
is simple to execute computationally using singular value decomposition (SVD)28, but it 
is limited by its linear nature.  This is illustrated by two examples of two-dimensional 
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data, Figure 4.1a where PCA reduces the data to a single dimension successfully, and 
Figure 4.1b where PCA finds the variance to be equally accounted for by any choice of 
two eigenvectors; the simple nonlinear pattern is not extracted.  Attempts have been made 
to design non-linear feature extraction algorithms29, which often rely on transforming the 
data into a set of distances between the input vectors, and subjecting those distances to a 
linear analysis.  In this work, I apply PCA to reduce unwieldy data sets for visualization 
with Andrews curves. 



























Figure 4.1: Two example data sets illustrating effective use of PCA.  PCA is capable 
of extracting a linear pattern such as in (a), where the variance in the data exists almost 
entirely along one eigenvector, but it is not capable of extracting a nonlinear pattern such 
as in (b), where PCA would report a roughly equal amount of variance along any two 
eigenvectors. 
 
Data Reduction Strategies: Model-Based Clustering 
Another challenge of gene expression analysis is performing computational tasks 
in a manner that is robust to noise, especially noise arising from the chosen method of 
gene expression data collection.  Cellular circuitry is subject to noise of biological origin, 
and sometimes relies on it for critical operations30.  It is a daunting challenge to separate 
the sources of noise in a complex process such as a gene regulation network, and 
although a number of sophisticated statistical tests have been proposed to help separate 
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machine noise from biological noise in gene expression studies31-35, a central goal of 
investigators is to develop methods for analysis that penetrate all types of noise to infer 
persistent correlations from the data.  The two general categories of noise that confound 
analytical techniques are strong outliers, which are small numbers of points that are 
relatively distant from associated points, and dense noise, which describes data where 
persistent corollaries are obscured by closely associate data that is easily confused for the 
feature of interest. 
The primary analytical method employed in the studies of Chu et al., Sorlie et al., 
and many other studies is a clustering algorithm that recursively binds the two vectors 
with the highest Pearson correlation coefficient into nodes until a single node is reached, 
resulting in a binary tree, or dendrogram15.  Such dendrograms can also be generated by 
top-down recursive bisection36.  Another common clustering algorithm that does not rely 
on multivariate statistics is k-means37.  K-means, after an initial set of cluster centroids is 
provided, alternates between assigning vectors to the nearest centroid and recalculating 
the values of the centroids from the vectors assigned to it, until convergence.  All of these 
heuristic methods are computationally efficient, parallelizable, and avoid pitfalls such as 
over-fitting and the curse of dimensionality.  However, these methods are not statistically 
robust. 
A variety of more sophisticated alternatives have been proposed that employ 
model-based clustering38-46, where the vectors are assumed to have been generated by 
some combination of probability distribution functions, and an algorithm is applied to 
compute one or more such combinations that aptly describe the data.  Although these 
methods can be very powerful, they challenge the investigator with new problems.  For 
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example, whereas the method of Eisen et al. is deterministic, most model-based methods 
are probabilistic searches for local extrema.  Furthermore, these methods require care to 
avoid overfitting and require significant preprocessing to help reduce the computational 
time for high-dimensional data. 
Mixture modeling is not widely applied to gene expression data.  In general, the 
technique is more suited to classifying genes than it is to classifying conditions, such as 
in the Sorlie et al. study.  The reason for this is that when classifying conditions, there are 
a small number of vectors (representing, e.g., 10-102 tissues) in a high-dimensional space 
(103-104 genes), and the large nondiagonal covariance matrices used to describe the 
clusters in this space will frequently become singular during the EM estimation.  Thus, 
without further modification, mixture modeling is best suited to cluster a large number of 
low-dimensional vectors, such as those from the Chu et al. data. 
A common, widely applied strategy for model-based clustering is to assume that 
the data arise from a linear combination of multivariate Gaussian distributions38,42,47, and 
employ an algorithm such as expectation-maximization48 to calculate the parameters of 
such a combination that maximize the probability that the model generated the input data.  
This method of clustering allows the investigator to use knowledge of inherent physics or 
experimental experience to select a model that will produce the most informative results 
for the data of interest.  Furthermore, because these methods are based on well-studied 
statistical models, other analytical problems such as selecting the number of clusters can 
also be approached from a fundamental statistical perspective.  Because Gaussian 
distributions will model data that lacks inherent Gaussian behavior poorly, investigators 
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have applied a number of heuristic methods for accounting for non-Gaussian behavior 
such as strong outliers32,40.   
McLachlan et al.  has proposed making use of mixtures of T-distributions (MoT), 











































    (Eq. 4.3) 
in order to model data that are significantly more noisy than those which are likely to be 
created by Gaussian distributions39,49,50.  In a T-distribution, the parameter ν is known as 
the degrees of freedom.  As this approaches infinity, the T-distribution tends to the 
Gaussian distribution (Fig. 4.2d), whereas in the limit of ν=1, the T-distribution tends to 





































Figure 4.2: Univariate T-distributions at several degrees of freedom.  This illustrates 
that as the number of degrees of freedom increase, the distributions become more 
Gaussian, and less permissive to outliers. 
 
Studies suggest that gene expression data generated by cDNA microarrays have a 
generally Gaussian distribution51.  The standard method of preprocessing popularized by 
Brown actually yields Lorentzian distributions because the final data is what is termed 
“ratio of medians,” and involves dividing one Gaussian-distributed data set by another 
(see Appendix A).  Despite this, it remains unknown what models serve to extract the 
most useful biological clusters from gene expression data.  Even if machine noise were 
entirely eliminated, investigators would still choose different models depending on the 
information they hope to gain.  Tolerance to outliers and dense noise remains a critical 
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requirement of any gene expression data clustering technique.  This work describes 
making use of Mixtures of Lorentzian distributions (MoL) to consistently identify 
persistent clusters despite the presence of both types of noise. 
 
4.2  Experimental 
 
 4.2.1  Algorithm for Clustering by Expectation-Maximization 
 















     (Eq. 4.4) 
as their fundamental basis.  Heuristically, Baye’s rule updates a prior hypothesis with 
posterior experimental knowledge.  The EM algorithm is designed to continuously 
improve the likelihood of the data over a set of model parameters by alternating between 
two steps.  The E-step calculates the log-likelihood of the full data set over the proposed 
parameters, and the M-step calculates a new set of parameters that maximize the log-
likelihood of the E-step.  This can be applied to optimize the parameters of a finite 
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The E-step, which is a form of Eq. 4.4, requires calculating the posterior probability τ 





























































1 τµ          (Eq. 4.10) 
 
updates the parameters over all data N, which are the means and covariances of the k 
Gaussian distributions, as well as the weighting factors, π.  Convergence is measured by 
the fractional change in the log likelihood of the complete model over the data; it tends to 
zero as the algorithm reaches a maximum log likelihood.  Initial values for the model 
parameters are provided either randomly or strategically by the investigator, and the 
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choice determines whether the EM algorithm will eventually reach a local or global 
maximum log likelihood. 
 The algorithm for Mixture of Lorentzians (MoL), adapted from McLachlan et 
al.,39 differs slightly from that of MoG (Eqs. 4.7-4.10).  The E-step requires calculating 
the posterior probability, τ,  and a second weighting factor, u, which is a function of δ, 














































       (Eq. 4.12) 
Once these are computed for the kth iteration, the M-step is performed to update the mean 
































































     (Eq. 4.14) 
The method of McLachlan et al. was further adapted by adding a heuristic cluster 
deletion algorithm to handle a problem of EM clustering of multivariate data.  In both 
MoG and MoL, the covariance matrix must be inverted, and if the covariance of a 
distribution has become close to singular, the calculation will fail.  This problem most 
commonly arises when the observations assigned to one cluster form a lower-dimensional 
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linear subspace. In order to overcome this, in our algorithm, when a cluster is nearly 
singular, it is deleted and the weighting factors for the remaining clusters are recomputed.  
This has the consequence of allowing the log likelihood to decrease between steps of the 
EM algorithm.  I refer to these algorithms as adaptive mixture of Gaussians or mixture of 
Lorentzians. 
 
 4.2.2  Computational Methods 
 
All experiments were conducting using MATLAB Release 13 (The Mathworks, 
Inc.), on one of several machines: Macintosh G4 running System X, IBM Pentium M 
running Windows XP Pro, Dual Pentium III running Redhat Linux, or Sun Ultra 60 
running Solaris 8.  Complete code for the Adaptive Mixture of Lorentzians, Adaptive 
Mixture of Gaussians, and utility software are in appendix B.   
 
 4.2.1  Sources of Data 
 
 All the data analyzed in this study were obtained from the Stanford Microarray 
Database (http://genome-www5.stanford.edu/).  In particular, the yeast data of Chu et al.7 
served as an example of a richly populated, low-dimensional space, and the extensive 
study of human breast cancer first described by Perou et al.52  served as an example of a 
sparsely populated, high-dimensional space.  Specifically, the breast cancer data were 
taken from Sorlie et al.10, supplemental table 6, and the yeast data was taken from the 
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entire data set of Chu et al.  No preprocessing beyond that embodied by particular 
algorithms was applied (for example, PCA requires centering of data). 
 
4.3  Results and Discussion 
 
 4.3.1  Andrews Curves 
 
 The study of Chu et al. uses cDNA microarrays to measure the expression of 
6118 genes of Sacchraromyces cerevisiae at seven time points during sporulation: 0, 0.5, 
2, 5, 7, 9, and 11 hours.  The genes that showed the greatest induction or repression 
during the experiment were classified into seven groups: Metabolic (52 genes), Early I 
(62), Early II (47), Early-Mid (95), Middle (158), Mid-Late (61), and Late (5).  For each 
of these classes, a subgroup of representative genes was used to create average expression 
patterns for the class (Table 4.1).   
Metabolic Early I Early II Early-Mid Middle Mid-Late Late 
ACS1 ZIP1 KGD2 YBL078C YSW1 CDC27 SPS100 
PYC1 YDR374C AGA2 QRI1 SPR28 DIT2 YKL050C 
SIP4 DMC1 YPT32 PDS1 SPS2 DIT1 YMR322C 
CAT2 HOP1 MDR1 APC4 YLR227C  YOR391C 
YOR100C IME2 SPO16 KNR4 ORC3   
CAR1  NAB4 STU2 YLL005C   
  YPR192W YNL013C YLL012W   
Table 4.1:  Genes used by Chu et al. to create average expression patterns for each 
of seven classifications. 
 
  I process the data in their entirety using principal components analysis (PCA) 
implemented by singular value decomposition (SVD).  In this case, the data are 
represented by 6118 vectors in 7-dimensional space.  The PCA analysis does not reduce 
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the length of the vectors.  The resulting 7 orthogonal subspaces are ranked in order of the 
fraction of the variance they account for in Figure 4.3. 












































Figure 4.3: The full data of Chu et al. is processed by PCA implemented with SVD.  
The resulting eigenvalues are used to show the fraction of the total variance explained as 
more principal components (eigenvectors) are included. 
 
 Chu et al. present the seven-dimensional data using the method of Eisen et al. 
described earlier, by assigning the expression level a color on a map from red (induced) 
to green (repressed) with black indicated an unchanged expression level.  Our alternative 
to this using Andrews curves maps the PCA-arranged vectors for the genes of interest 
onto an orthogonal Fourier subspace that preserves the mathematical relationships 
between the original vectors and allows viewers to properly infer the distance between 
vectors as the distance between lines on the Andrews plot. 
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 The first visualization task is to distinguish clustered vectors from unclustered 
vectors.  This is demonstrated in Figure 4.4, where six clustered metabolic genes (ACS1, 
PYC1, SIP4, CAT2, ORF YOR100C, CAR1) yield proximal Andrews curves, and three 
randomly selected, unclustered genes (ORFs YAR052C, YAR053W, YAR060C ) do not.  
This visualization can be accomplished with as few as three principal components (Fig. 
4.5).   
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Figure 4.4: After PCA processing, the data of Chu et al. is mapped onto the 
Andrews space and plotted. In black, six genes designated as belonging to the 
metabolic class (ACS1, PYC1, SIP4, CAT2, ORF YOR100C, and CAR1), and in red, 
three random genes (ORFs YAR052C, YAR053W, and YAR060C).  Here, all seven 
principal components are used for the Andrews plot. 
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Figure 4.5: After PCA processing, the data of Chu et al. is mapped onto the 
Andrews space and plotted. In black, six genes designated as belonging to the 
metabolic class (ACS1, PYC1, SIP4, CAT2, ORF YOR100C, and CAR1), and in red, 
three random genes (ORFs YAR052C, YAR053W, and YAR060C).  Here, only three 
principal components are used for the Andrews plot. 
 
 The second visualization task is to distinguish one group of clustered vectors from 
another similarly clustered group.  In Figure 4.6, Andrews curves are used to distinguish 
3 metabolic genes (ACS1, PYC1, SIP4) from 3 middle genes (YSW1, SPR28, SPS2). 
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Figure 4.6: After PCA processing, the data of Chu et al. is mapped onto the 
Andrews space and plotted. In black, three genes designated as belonging to the 
metabolic class (ACS1, PYC1, SIP4), and in red, three genes designated as belonging to 
the middle class (YSW1, SPR28, SPS2).  Here, all seven principal components are used 
for the Andrews plot. 
 
 The effect of altering the number of principal components used for Andrews plot 
is illustrated in Figure 4.7, where a different, but usable perspective is presented using 
between 4 and 7 principal components.  It is especially helpful to examine a range of 
principal components when distinguishing between groups of proximal vectors.  For 
example, if three genes from the middle class (ORC3, ORF YLL005C, ORF YLL012W) 
are compared to three genes from the mid-late class (CDC27, DIT2, DIT1), the resulting 
Andrews plots vary widely in their usefulness across the range of 4 to 7 principal 
components (Fig. 4.8).   
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Figure 4.7: After PCA processing, the data of Chu et al. is mapped onto the 
Andrews space and plotted. In black, three genes designated as belonging to the 
metabolic class (ACS1, PYC1, SIP4), and in red, three genes designated as belonging to 
the middle class (YSW1, SPR28, SPS2).  Here, the data are plotted for four choices of 

















































Figure 4.8: After PCA processing, the data of Chu et al. is mapped onto the 
Andrews space and plotted. In black, three genes designated as belonging to the mid-
late class (CDC27, DIT2, DIT1), and in red, three genes designated as belonging to the 
middle class (ORC3, ORF YLL005C, ORF YLL012W).  Here, the data are plotted for 
four choices of number of principal components. 
 
 
  I also apply the method of Andrews to the reduced breast cancer data of Sorlie et 
al., which are represented as a set of 122 vectors in 552-dimensional space.  All of the 
microarray analyses conducted using the 122 tissue samples measured the expression 
level of many thousands of genes, but the data were subsequently reduced to a subset of 
552 genes that met Sorlie et al.’s definition of “intrinsic.”  Briefly, these genes’ 
expression levels vary greatly among patients, but minimally between pairs of samples 
drawn from the same patient.  The investigators robustly cluster the tumor data into five 
classes: Normal, Luminal A, Luminal B, Basal, and ERBB2+.  These classes strongly 
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correlate with patient outcome as measured by time to distant metastasis.  Outcomes are 
best for patients whose tumors are classified as Luminal A, and become progressively 
worse for Luminal B, Basal, and are the worst for ERBB2+. 
 The 122x552-dimensional space is sparsely populated, and cannot support more 
than 122 independent linear subspaces.  Further, it will be necessary to reduce the number 
of dimensions to fewer than 10, the point where Andrews curves become intelligible.  
Thus, for these data, PCA will accomplish significant dimensional reduction, as well as 
ordering the eigenvectors in order of statistical importance.  Compared to the data of Chu 
et al., the Sorlie et al. data is much less easily explained by a small number of principal 
components (Fig. 4.9). 












































Figure 4.9: Plot of analysis of PCA reduction of data of Sorlie et al. implemented 
with SVD.  The resulting eigenvalues are used to show the fraction of the total variance 
explained as more principal components (eigenvectors) are included. 
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Table 4.2:  The reduced data of Sorlie et al. is processed by PCA implemented with 
SVD.  The largest number of principal components (PCs) that can realistically be 
visualized with Andrews curves accounts for approximately 21.9% of the variance in the 
data. 
 
 Despite the limited explaining power of 1-10 principal components for the Sorlie 
et al. data, Andrews curves can still helpfully visualize tumor classes.  When applied to 
three tumors from the Luminal A class (Norway FU15-BE, Norway FU37-BE, Norway 
FU16-BE) and three tumors from the ERRB2+ class (Northway FU18-BE, Norway 
FU04-BE, Norway 65-2ndT), the resulting Andrews curves vary in usefulness over the 
range from 4 to 7 principal components used (Fig. 4.10); notably, 5 principal components 
(Figure 4.10c) may offer more visual appeal than 4, 6 and 7.  Similarly, in Figure 4.11, 
three tumors from the Normal class (Benign STF 37, Benign STF 20, Benign STF 11 can 
be distinguished from three from the Basal class (Norway FU12-BE, Norway FU23-BE, 
Norway FU39-BE), but most easily with 4 principal components (Fig. 4.11d). 
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Figure 4.10: After PCA processing, the data of Sorlie et al. is mapped onto the 
Andrews space and plotted. In black, three tumors designated as belonging to the 
Luminal A class (Norway FU15-BE, Norway FU37-BE, Norway FU16-BE), and in red, 
three tumors from the ERRB2+ class (Northway FU18-BE, Norway FU04-BE, Norway 














































Figure 4.11: After PCA processing, the data of Sorlie et al. is mapped onto the 
Andrews space and plotted. In black, three tumors designated as belonging to the 
Normal class (Benign STF 37, Benign STF 20, Benign STF 11), and in red, three tumors 
from the Basal class (Norway FU12-BE, Norway FU23-BE, Norway FU39-BE).  Here, 
the data are plotted for four choices of number of principal components. 
 
 4.3.2  EM Clustering of Synthetic Data 
 
 In order to illustrate the differences between the MoG and MoL algorithm, 
experiments were conducted on a series of strategically designed artificial 2-dimensional 
data sets.  The first of these, Artificial Data Set 1 (ADS1), uses the data depicted in 
Figure 4.12 to illustrate the difficulty MoG has in locating the mean of a persistent cluster 
of points when noise is present.  The MoG result shown in Figure 4.13(a) is a large 
Gaussian distribution with a mean far from the mean of the main cluster of points.  This 
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happens because the Gaussian distribution pays a large likelihood penalty for distant 
outliers.  On the other hand, the MoL result shown in Figure 4.13(b) correctly identifies 
the mean of the persistent cluster. 
 









Figure 4.12: Artificial Data Set 1, which contains one persistent cluster and a small 






Figure 4.13: Artificial Data Set 1, after execution of the EM-MoG (a) or EM-MoL 
(b) algorithm.  In (a), the probability density function for the Gaussian distribution must 
be quite large in order to explain the distant points, where as the Lorentzian PDF in (b) 
located the mean of the persistent cluster and ignores the distant points. 
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 The second artificial data set (ADS2, Fig. 4.14) is designed to further illustrate the 
manner in which the MoG algorithm is confounded by a small number of outliers.  In this 
case, it is clear to the naked eye that there are two clusters.  In 100 trials, the MoG 
algorithm failed to find the true clusters every time, as shown in Figure 4.15(a), whereas 
the MoL algorithm successfully found the true clusters every time, as shown in Figure 
4.15(b).  The plots of the PDFs indicate that the MoG algorithm (Fig. 4.16(a)), is forced 
to include all of the outliers in one extremely diffuse cluster in order to account for them, 
whereas the MoL algorithm (Fig. 4.16(b)) results in two tight PDFs. 
 












Figure 4.14: Artificial Data Set 2, which contains two tight clusters and a small 
number of outliers. 
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Figure 4.15: Artificial Data Set 2, after execution of the EM-MoG (a) or EM-MoL 
(b) algorithm.  In (a), the MoG algorithm is confounded by the outliers and reaches a 
maximum likelihood at two clusters with their means (black circles) between the true 





Figure 4.16: Artificial Data Set 2, after execution of the EM-MoG (a) or EM-MoL 
(b) algorithm.  In (a), the PDFs of the two Gaussian clusters overlap along the centerline 




 The third artificial data set (ADS3, Fig. 4.17) is designed to illustrate the 
confounding effect of dense noise on the MoG algorithm.  Unlike ADS1 and ADS2, the 
non-deterministic nature of EM-MoG and EM-MoL is an important factor for ADS3.  
Depending on the initial choices for the mean and covariance, the EM algorithm will 
converge to a variety of local maxima.  For ADS3, each algorithm was executed 100 
times with random initializations.  The most probable outcomes (Fig. 4.18) are successful 
identification of the “faint” clusters by MoL, and complete failure by MoG.  The PDFs 
corresponding to these outcomes (Fig. 4.19) verify that MoL correctly identifies the 
persistent clusters and MoG is confounded by the dense noise. 













Figure 4.17: Artificial Data Set 3, which contains three faint clusters and a large 
amount of dense noise. 
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Figure 4.18: Artificial Data Set 3, after execution of the EM-MoG (a) or EM-MoL 
(b) algorithm, with the most probable outcome shown.  In (a), the MoG algorithm is 
confounded by the noise and provides three clusters with incorrect means (black circles). 
In (b), the MoL algorithm correctly identifies the true clusters, although the assignment 





Figure 4.19: Artificial Data Set 3, after execution of the EM-MoG (a) or EM-MoL 
(b) algorithm.  In (a), the PDFs of the three Gaussian clusters spread across the data in 
an unintuitive manner, whereas in (b) the PDFs are small and centered at the true clusters. 
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 ADS3 also provides an opportunity to test the robustness of the EM-MoL and 
EM-MoG algorithms to random initial conditions.  This may be especially important for 
gene expression data, when unsupervised clustering is often done in the absence of prior 
information for the initialization.  In 100 trials (Fig. 4.20) the MoL algorithm identifies 
the correct clusters nearly every time (Fig. 4.21(a)), whereas the MoG algorithm rarely 
identifies the correct clusters (Fig. 4.21(b)).  













Figure 4.20: Artificial Data Set 3, after execution of the EM-MoG and EM-MoL 
algorithm over 100 trials.  The data points are the black dots, the means proposed by 
MoG are the blue circles, and the means proposed by MoL are the red crosses.  
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Figure 4.21: Artificial Data Set 3 was processed by 100 trials of the EM-MoG (a) 
and EM-MoL (b) algorithms.  The means of the proposed PDFs were binned into a 
histogram.  Because the y-coordinates of the means of two of the true clusters are very 
similar, the y-coordinate histogram of (b) has a 200-count bin.  
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In most artificial data sets, the MoL algorithm not only produces heuristically 
superior results, but it also produces higher values for the log likelihoods of the proposed 
models when compared to MoG.  This may not be a good way to compare the relative 
performance of MoG and MoL across all data sets.  The Gaussian distribution gives very 
large likelihood bonuses to points near its mean, since the distribution is quite peaked.  
Thus, even for clusters with outliers, the MoG likelihood may be higher than the MoL 
likelihood, even when the means are mislocated. 
 
4.3.3  EM Clustering of Gene Expression Data 
 
  I also test the performance of the EM-MoG and EM-MoL algorithms on a 
reduced form of the data set from the Chu et al. study.  The data were limited to 477 
genes that were identified by Chu et al. as belonging to one of the seven temporal classes 
defined by a common time of induction.  The seven true clusters are numbered from 1 to 
7, Metabolic, Early I, Early II, Mid-Early, Middle, Mid-Late, and Late.  Mixture models 
will not be able to mimic this classification perfectly without further preprocessing, 
because two genes with similar times for induction may have quite different overall 
temporal profiles, and thus distant vectors in seven-dimensional space.    
With this potential limitation in mind, the algorithms were executed with 2 
randomly initialized clusters, with the hope that the algorithms would classify the points 
into two groups, an early-induction group and a late-induction group.  In both algorithms, 
after the criteria for maximum likelihood is reached, the algorithm-assigned labels of 477 
genes are plotted in a confusion matrix against the true labels.  In the case of seven 
 130
clusters, if the data are perfectly classified, then each rank or file of the confusion matrix 
will have genes in only one file or rank.  In the case of two clusters, as in Figure 4.21, a 
qualitatively correct proposed cluster would contain one or more adjacent true clusters.  
In Figure 4.22(a), the MoG algorithm yields proposed cluster 1 that contains more than 
half of the true cluster 1 (Metabolic), but also a significant amount of true cluster 6 (Mid-
Late) and all of true cluster 7 (Late).  This may be analogous to the effect seen in Figure 
4.15(a), where the Gaussian distribution is unable to partition two clusters surrounded by 
a great deal of noise.  By comparison, the MoL algorithm (Fig. 4.22(b)) yields two 
clusters well relatively well defined boundaries.  Proposed cluster 1 contains most of the 
Middle to Late genes, whereas proposed cluster 2 contains the early genes, with the 





Figure 4.22: Confusion matrices for results of 477 pre-classified genes from the data 
set of Chu et al. analyzed by EM-MoG and MoL with 2 randomly initialized 
clusters.  In (a), MoG proposes two relatively diffuse clusters, whereas in (b), MoL 




 When the EM-MoG and EM-MoL algorithms seek seven clusters to match the 
seven temporal classes, the results are not easily distinguished from one another (data not 
shown).  Neither algorithm reproducibly generates qualitatively accurate confusion 
matrices.   
Another problem of mixture modeling approaches to clustering is selecting he 
optimal number of clusters.  In some cases, such as with Chu et al., there is an established 
classification scheme.  In other cases, the number of clusters must also be hypothesized.  
Here, I make use of the minimum description length (MDL) term53 to penalize the 
likelihood of the mixture model as the number of parameters increases.  For this case, the 
MDL penalty reduces to subtracting half of the number of parameters times the log 
likelihood from the as-computed likelihood.   I then executed the MoG (Fig. 4.23(a)) and 
MoL (Fig. 4.23(b)) algorithms on the full Chu et al. data set, and applied the MDL 













































Figure 4.23: Plot of the likelihood of fit of full data set of Chu et al analyzed by EM-
MoG (a) and EM-MoL (b) with 1 to 30 randomly initialized clusters, with and 
without the inclusion of the MDL penalty term.  With the penalty term, both clustering 




Cluster Size Mean for MoL St. Dev Mean for MoG St. Dev.
2 -63644 2.9 -61886 0.4
3 -63385 42.8 -61383 87.0
4 -63217 38.3 -61079 55.7
5 -63095 54.9 -60912 52.2
6 -63035 48.5 -60833 45.5
7 -63003 45.3 -60797 32.2
8 -62973 39.0 -60787 41.2
9 -62990 29.2 -60807 49.7
10 -63015 35.8 -60807 30.1
11 -63058 28.9 -60851 25.2
12 -63088 27.5 -60892 44.8
Average Standard Deviation  39.0  46.4
Table 4.3: Likelihoods of fit for the full data set of Chu et al analyzed by EM-MoG 
and EM-MoL with 1 to 12 randomly initialized clusters, with the inclusion of the 
MDL penalty term. For each choice of cluster size, each algorithm was executed 30 
times to generate the statistics shown. 
 
 The behavior of the two algorithms can be illustrated by examining the PDF of 
one of the proposed clusters.  In Figure 4.24(a), a representative cluster from the MoG is 
shown in seven panels where each panel is a histogram of the nth-dimension value of 
each vector assigned to that cluster.  The data in the cluster is distributed in a roughly 
Gaussian fashion, as shown by the fits.  The MoL algorithm similarly finds Lorentzian 
distributions (Fig. 4.24(b)), but qualitatively generates clusters that are more 




















































































Figure 4.24: Histograms of cluster fits for the full data set of Chu et al analyzed by 
EM-MoG (a) and EM-MoL (b) with 7 randomly initialized clusters.  One of the 
clusters was broken down into its seven dimensions, and each dimension was binned into 




4.4  Summary 
 
 I have demonstrated the combination of principal components analysis and 
Andrews curves for the visualization of gene expression data.  The combination method 
was applied to visualizing gene vectors in condition space using data from the study of 
Chu et al., as well as to visualizing condition vectors in gene space using data from the 
study of Sorlie et al.  The method is based in well-studied linear algebraic theory, and 
results in heuristically useful depictions of multivariate gene expression data.  Using this 
method, clustered vectors can be distinguished from both unclustered vectors and 
differently clustered vectors. 
  I have implemented the expectation-maximization algorithm to optimize a linear 
mixture of Lorentzian distributions for clustering.  When compared to the equivalent 
algorithm for Gaussian distributions, the EM-MoL algorithm offers several advantages 
when applied to artificial two-dimensional data.  The EM-MoL algorithm more 
accurately calculates the means of clusters it identifies, it is more robust to far outliers, 
and it robustly identifies persistent clusters in a field of dense noise. 
  I have further compared the EM-MoG and EM-MoL algorithms by clustering the 
data of Chu et al.  Neither algorithm consistently replicates the classifications of the 
original study, however when tested with two clusters, the EM-MoL algorithm reliably 
partitions the data into earlier-induction and later-induction groups, whereas the EM-
MoG algorithm does not.  I applied the minimum description length penalty term to show 
that both algorithms estimate that there are between 7 and 9 clusters in the Chu et al. 
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data.  Lastly, I showed that the algorithms generate clusters that are well modeled by their 
respective probability distribution functions, and that with the Chu et al. data, EM-MoG 
forms more irregular clusters than EM-MoL. 
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5.1 Peptoid Synthesis 
 
 I demonstrated several new synthetic strategies for expanding the versatility of the 
peptoid platform.  Three further areas may be worth investigation. 
The first area includes three new modifications for use in our MAGE assay, where 
I made use of peptoid-DNA conjugates that were formed by modifying the N-terminus of 
the peptoids with iodoacetic acid.  It would be useful to transfer two other features 
currently embedded at the 5′ end of the oligodeoxynucleotide in MAGE: a pendant 
visible dye, and a backbone photocleavable linker.  By moving these specialized 
functionalities from the ODN to the peptoid, it would increase the generality and decrease 
the cost of MAGE.  I have demonstrated (data not shown) a system where the dye is 
added at the N-terminus, and a pendant iodoacetyl group is used for subsequent 
conjugation to the ODN thiol, but the yield of the synthesis remains poor (Appendix C.1).  
Attempts to incorporate photocleavable units into the backbone with pendant 
orthonitrobenzenes and similar moieties have failed (Appendix C.2).  It is likely that a 
successful strategy will incorporate not only this functionality but also a bond that is 
more subject to photo-initiated degradation than the amide bonds in the peptoid.  Finally, 
because peptoids can incorporate great diversity through the amine submonomers, it may 
be possible to improve the mass spectrometric efficiency of the peptoids by carefully 
choosing submonomers.  For example, the extent of fragmentation could be reduced, or 
the ionization efficiency could be increased.  I synthesized a number of peptoids 
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incorporating polar, aromatic primary amine submonomers in an attempt to increase the 
MALDI ionization efficiency of the peptoid tags.  The motivation for this was that many 
MALDI matrices share structural features with the chosen submonomers.  There was no 
evidence that this tactic was effective (Appendix C.3). 
The second area is gene therapy.  Cationic peptoids have been studied for gene 
therapy1,2, but thus far the only cationic amine submonomers have been primary amines.  
The literature of gene therapy suggests that other charge centers, such as amidines, have 
intriguing properties3.  Because they are sequence-specific heteropolymers, peptoids 
would be an ideal platform for structure-function studies of oligoamines and 
oligoamidines.  Amidine groups could be incorporated into peptoids by making use of 
mono-protected diamines, deprotecting those amines at the end of the synthesis, and 
modifying them with a reagent such as ethyl acetimidate.  My work and the work of 
others4 has demonstrated a wide variety of chemoselective functionalities that can be 
incorporated into peptoids, so these oligomers could be conjugated to dyes and other 
entities of interest to gene therapy. 
The third area is extended molecular structures, exemplified by the work of 
Mirkin et al.5,6 In general, of the field of nanoscale assembly, Mirkin reports that “a 
major limitation in nanoparticle-based materials chemistry is the lack of suitable 
assembly methods for preparing extended two- and three-dimensional architectures with 
synthetically programmable building block and assembly parameters.”   He also claims of 
a system of DNA-block copolymer conjugates that “while interesting, these 
DNA/polymer hybrids are limited with respect to their degree of tailorability, ill-defined 
compositions, and poor solubilities and dispersities, as well as function.”  Peptoids could 
 147
be a suitable system for these types of investigations.  For example, to create extended 
molecular structures of peptoids and DNA, the branching scheme presented in this thesis 
could be combined with our method of peptoid-DNA conjugation.  By tailoring the 
structure of the peptoid, the properties of the resulting extended structure could be 
controlled.  It would also be possible to incorporate other nanoscale objects of interest 
into these scaffolds, such as large biomolecules, or quantum dots.  Quantum dots are 
themselves an interesting potential application of peptoids. Modifying the surface 
properties of gold and silver and other nanoparticles affects their behavior as light 
emitters, as well as their stability in solution.  Attaching peptoids to nanoparticles (e.g., 
via a thiol-based linker) gives a tunable way to modify the properties of the particles 
through the sequence of the peptoid. 
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5.2 MAGE Methodology 
 
 Each component of the MAGE methodology was demonstrated with elementary 
proof-of-principle experiments.  Currently, the major limitation of MAGE is that it can 
only be as sensitive as the mass spectrometer that is used for the final quantitation.  
Immediately stemming from the first experiments, I would suggest that (i) the 
hybridization kinetics of the MAGE probes and likely targets be studied, (ii) the 
quantitativeness of the ligation step be assessed, (iii) the ultimate sensitivity of peptoid-
containing MAGE fragments be studied in a variety of mass spectrometers, and (iv) 
“reversed” MAGE probes be tested to try to eliminate the multiple photocleavage 
products.  Experiments (i) and (ii) are critical for proving that MAGE establishes a 1:1 or 
other predictable relationship between mass tags and sequences of interest.  In particular, 
it might be especially important to identify an optimal time and temperature of 
hybridization for the MAGE probes and targets by tracking duplex formation for a 
variety of choices of target initial concentration, temperature, and time.  These studies 
might also determine what relative concentration of probes is necessary to ensure pseudo-
first-order kinetics.  Currently, it is unknown what effect the peptoid and biotin may have 
on the hybridization kinetics.  Experiment (iv) could be conducted with commercially 
available phosphoramidites from Glen Research, including 5′-biotin phosphoramidite, 3′-
thiol-modifier C3 S-S CPG, PC spacer phopsphoramidite, and 3′-phosphate CPG, 
resulting the new probes M3 and M4  in Figure 5.1.  This new configuration would mean 
that the peptoid fragment would carry the phosphate half of the photocleavage reaction 
 149
instead of the linker residue (Fig. 5.2).  The phosphate half did not show by RP-HPLC 

























































































Figure 5.1: Schematic illustrated of MAGE probes in different orientations.  Probes 
M1 and M2 are in the configuration used in this thesis.  By reversing the probes to the 
configuration shown in M3 and M4, the peptoid fragment of photocleavage would be a 














































Figure 5.2: Schematic illustrated of alternative MAGE peptoid fragments.  By 
reversing the configuration of the probes, the peptoid fragment of MAGE is changed 




Following these fundamental experiments, I would suggest attempting to (i) 
multiplex MAGE by synthesizing a small group of peptoid mass tags, (ii) compare 
MAGE measurements to those of competing technologies, (iii) test the discriminating 
power of the ligation step by using a thermostable ligase and probing for targets with 
slightly mismatched competitors present, and (iv) execute the final quantitation on more 
sensitive mass spectrometers than the one employed for our studies.   
Three other potential modifications of MAGE might be of interest.  First, the 
flexibility of the isotopic labeling system could be used to enable “multi-color” MAGE.  
Here, instead of comparing the sample of interest to a calibrated internal standard, two or 
more target samples are simultaneously interrogated by probes with peptoid tags of 
identical sequence but differing amounts of isotopic labeling.  For example, four peptoids 
could be synthesized, each different by six Daltons.  One of the four would be used for 
each of four different target mixtures, and the resulting cleaved tags would be mixed 
prior to mass spectrometry.  This would be especially useful for examining time-course 
gene expression data, and it would be the equivalent of a four-color microarray. 
Second, if the state-of-the-art mass spectrometry equipment does not yield 
sufficient sensitivity, amplification schemes should be considered.  The focus in the field 
of mass spectrometry has been mass accuracy, not sensitivity.  This is in part why two 
schemes of mass-spectrometric gene expression analysis have relied on amplification7,8.  
The most obvious choices for an amplification scheme for MAGE would be those based 
on the ligation detection reaction9-11.  The two common schemes both require adding 
additional cycles of ligation.  In the current implementation of MAGE, after the probes 
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have been annealed and ligated, the mixture could be melted and reannealed, and ligated 
again.  Assuming that an excess of probes was added, this would result in a linear 
amplification of the signal.  A more drastic step would be to add a second set of probes 
that are complementary to the first set (and thus, identical to the targets).  Here, repeated 
rounds of ligation results in an exponential amplification, known as ligase chain reaction 
(LCR).  In order to ensure that the signal is not confounded by blunt-end ligation, a gap 
could be left between the two probes instead of a nick12,13, known as Gap-LCR. 
Third, in order to decrease costs and increase reliability, the MAGE methodology 
could be implemented in a chip format.  All of the technological steps of MAGE have 
been demonstrated in some combination on chips, starting from the purification of 




5.3 Visualization and Model-Based Clustering 
 
Andrews curves are a mathematically rigorous, visually effective method for 
displaying multivariate data.  There are several key limitations that were evident in my 
work.  First, it is not effective to attempt to plot more than about 10 vectors 
simultaneously, because the plot becomes too densely packed to interpret.  Second, it is 
not effective to attempt to plot more than the first 7-10 terms of the Fourier series, 
because the curves become exceedingly squiggly.  Third, the terms of the Fourier series 
have a decreasing impact on the appearance of the plot16.  Because of these limitations, it 
is critical that some preprocessing step be applied to the high-dimensional gene 
expression data.  Principle components analysis (PCA) is effective, as I demonstrated, but 
it is not optimal in this application.  PCA creates a set of orthogonal linear spaces in 
decreasing order of their eigenvalues, serving to extract linear features from the data.  
There is some evidence suggesting that there are significant linear features within gene 
expression data17, and my results seem to suggest this as well.  Ultimately, because of the 
highly non-linear nature of massively-fedback networks such as those present in the cell, 
linear methods will fail to extract all of the significant features.  In further pursuit of this 
visualization method, non-linear preprocessing methods should be considered18-21. 
As evidenced by the proliferation of alternative methods, it is quite difficult to 
determine the most appropriate method for clustering analysis on gene expression data. 
The mixture of Lorentzians model I presented offers an extremely permissive set of 
clusters that avoids heuristic “outlier rejection” methods that are often employed.  The 
 153
advantages of my method are evident from artificial data, but it remains difficult to 
conclude that it represents a superior clustering algorithm for gene expression data in 
general.  Part of the reason for this is that it remains largely unknown what the true nature 
of the biological noise of transcription is, as well as the machine noise inherent to various 
types of gene expression analysis systems.  Currently, the most successful strategies seek 
to test a number of different clustering schemes in combination with non-parameterized 
statistical tests such as Monte Carlo cross-validation or bootstrap analysis22.  Another 
important feature of a fully-developed clustering scheme is a scheme for developing a 
hierarchy of clusters.  Superior hierarchical schemes are two-way, where each node in the 
hierarchy can have multiple children as well as multiple parents.  Further development of 
the mixture of Lorentzians algorithm should seek to include it in a hierarchical algorithm 





 Studies of functional genomics draw from a diverse pool of experimental and 
analytical methods.  In recent years, investigators have demanded high quality data with 
robust statistical analyses to support their increasingly quantitative studies.  Here, we 
have offered a new method for unambiguously measuring the abundance of specific 
sequences of nucleic acids.  Because it is grounded in well-studied physics, and results in 
absolute abundances, the MAGE methodology is especially suited for these highly 
quantitative studies.  In order to meet the demand for new, statistically robust analytical 
methods, I have presented several new tactics for large-scale gene expression analysis.  
Used in combination, my methods allow investigators to reduce their expansive data to a 
more manageable subset using principle components analysis, visualize that data in a 
mathematically consistent and useful manner with Andrews curves, and cluster their data 
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APPENDIX A: DERIVATION OF A LORENTZIAN DISTRIBUTION FROM 









Let X and Y be two independent normally distributed random variables with mean zero 
and standard deviation 1, 
 
X=G(0,1); Y=G(0,1)  
 
 
Since X and Y are independent, their joint probability distribution function is the product 












Now we can obtain the probability distribution for z = x/y by integrating out the w 
dependence of  fzw 
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B.1 Master algorithm function for generating Andrews curves 
 
 
function [] = Demon_Andrews(LabeledData,npcs); 
%Andrews Curve Demonstrator 
%LabeledData should have the data arrange in columns, so that the 
%number of rows is the number of dimensions, and the number of columns 
%is the number of samples.  The last row should contain labels, which 
are 
%integers from 1 up. 
%npcs is the number of principle components you wish to use.  This 
number 
%should be at least 1, and at most either the number of samples or the 
number 















%First we preprocess the data to reduce the data to the number of PCs  
%desired 
 
[ProcData] = preproc(LabeledData,X,npcs); 
size(ProcData) 
 
%We illustrate the effect of this processing 
 












%title('Cumulative explaining power of all principal components') 
ylabel('% of Variance Explained by principal components 1 through 122') 
xlabel('Principal components used') 
hold 
%line([npcs npcs],[0 100]) 




%Now the data is processed using Andrews' Method 
%Andrews' Method is a simple mapping onto an orthogonal basis function 
that 
%preserves the mathematical integrity of the data 
 
for i=1:N 























%Now we take the Andrews Method processed Data and show it 




































   LPCA([1:D],i)=PCAdata(:,i); 
   LPCA(D+1,i)=assignedata(D+1,i); 








function [pc, explained, score, latent, tsquare] = MakePCA(q); 
 
[m,n] = size(q); 
avg = mean(q); 
centerx = (q - avg(ones(m,1),:)); 
 
[U,latent,pc] = svd(centerx./sqrt(m-1),0); 
score = centerx*pc; 
explained=100*(diag(latent))/(sum(diag(latent))); 
 
if nargout < 4, return; end 
latent = diag(latent).^2; 
 
if nargout < 5, return; end 




B.4 EM adaptive mixture of Lorentzians 
 
 









for i=1:K   
    
 Mean(:,i)=randMean(D,1); 
 test=500; 
 while test>=100 
  Cov(:,:,i)=randCovariance(D,20); 
  test=cond(Cov(:,:,i)); 
 end 
 F(i)=1/K; 












 for i=1:K 
  U=X-repmat(Mean(:,i),1,N); 
  V=U.*(inv(Cov(:,:,i))*U); 





 for i=1:K 
    








 if ITS>1 














 for i=1:K 
 
  M1=repmat(Mean(:,i),1,N); 
  Y=X-M1;  
     R1=repmat(R(i,:),D,1); 
  Cov(:,:,i)=((Y.*R1)*Y')/T(i); 
   
  if cond(Cov(:,:,i))>=1e10 
   disp('Covariance Failure, eliminating') 
   ClusterFlag=i 
   PointsInCluster=N*F(i) 
  end 
   
 end 
 if ClusterFlag~=0 
  g=1; 
  for j=1:K 
   if j~=ClusterFlag 
    Mean2(:,g)=Mean(:,j); 
    Cov2(:,:,g)=Cov(:,:,j); 
    F2(g)=F(j); 
    g=g+1; 
   end 
  end 
  Mean=Mean2; 
  Cov=Cov2; 
  F=F2/sum(F2); 
  K=K-1; 
  clear M;clear U;clear V;clear R;clear P1;clear S; 
  clear T;clear M1;clear R1;clear Y; 
  end  







B.5 EM adaptive mixture of Gaussians 
 
 









for i=1:K   
    
 Mean(:,i)=randMean(D,1); 
 test=500; 
 while test>=100 
  Cov(:,:,i)=randCovariance(D,20); 
  test=cond(Cov(:,:,i)); 
 end 
 F(i)=1/K; 












 for i=1:K 
  U=X-repmat(Mean(:,i),1,N); 
  V=U.*(inv(Cov(:,:,i))*U); 





 for i=1:K 
    







 if ITS>1 











 for i=1:K 
 
    
     R1=repmat(P(i,:),D,1); 
  Cov(:,:,i)=((X.*R1)*X')/S(i)-Mean(:,i)*Mean(:,i)'; 
   
  if cond(Cov(:,:,i))>=1e10 
   disp('Covariance Failure, eliminating') 
   ClusterFlag=i 
   PointsInCluster=N*F(i) 
  end 
   
 end 
 if ClusterFlag~=0 
  g=1; 
  for j=1:K 
   if j~=ClusterFlag 
    Mean2(:,g)=Mean(:,j); 
    Cov2(:,:,g)=Cov(:,:,j); 
    F2(g)=F(j); 
    g=g+1; 
   end 
  end 
  Mean=Mean2; 
  Cov=Cov2; 
  F=F2/sum(F2); 
  K=K-1; 
  clear M;clear U;clear V;clear R;clear P1;clear S; 
  clear T;clear M1;clear R1;clear Y; 
  end  








B.6 Mixture of Lorentzians with plotting for 2D data sets 
 
 









for i=1:K   
    
 Mean(:,i)=randMean(D,1); 
 test=500; 
 while test>=100 
  Cov(:,:,i)=randCovariance(D,20); 
  test=cond(Cov(:,:,i)); 
 end 
 F(i)=1/K; 












 for i=1:K 
  U=X-repmat(Mean(:,i),1,N); 
  V=U.*(inv(Cov(:,:,i))*U); 





 for i=1:K 
    








 if ITS>1 














 for i=1:K 
 
  M1=repmat(Mean(:,i),1,N); 
  Y=X-M1;  
     R1=repmat(R(i,:),D,1); 
  Cov(:,:,i)=((Y.*R1)*Y')/T(i); 
   
  if cond(Cov(:,:,i))>=1e10 
   disp('Covariance Failure, eliminating') 
   ClusterFlag=i 
   PointsInCluster=N*F(i) 
  end 
   
 end 
 if ClusterFlag~=0 
  g=1; 
  for j=1:K 
   if j~=ClusterFlag 
    Mean2(:,g)=Mean(:,j); 
    Cov2(:,:,g)=Cov(:,:,j); 
    F2(g)=F(j); 
    g=g+1; 
   end 
  end 
  Mean=Mean2; 
  Cov=Cov2; 
  F=F2/sum(F2); 
  K=K-1; 
  clear M;clear U;clear V;clear R;clear P1;clear S; 
  clear T;clear M1;clear R1;clear Y; 
  end  
end    
 










%This part plots all the data, different colors for different clusters, 
up to 








 switch mod(assigneddata(3,i),10) 
  case 0, 
   plot(X(1,i),X(2,i),'c*') 
  case 1, 
   plot(X(1,i),X(2,i),'rd') 
  case 2, 
   plot(X(1,i),X(2,i),'gv') 
  case 3, 
   plot(X(1,i),X(2,i),'m+') 
  case 4, 
   plot(X(1,i),X(2,i),'bs') 
  case 5, 
   plot(X(1,i),X(2,i),'yo') 
  case 6, 
   plot(X(1,i),X(2,i),'wx') 
  case 7, 
   plot(X(1,i),X(2,i),'yp') 
  case 8, 
   plot(X(1,i),X(2,i),'r<') 
  case 9, 
   plot(X(1,i),X(2,i),'g>') 
  otherwise, 













B.7 Utility for running multiple clustering experiments 
 
 
function [] = molexp(reps,m,n,fname) 
%molexp(reps,m,n,fname) 
%Reps is the number of times to conduct the MDL experiment 
%Experiment does MoG, m-n clusters, reps times 






 for j=1:reps 
  currentrepetition=j 
  currentcluster=i 
  [Likelihood, Mixture_coefficients, Means, Covariances] = 
MoLv4(X,i); 
  Results(f,1)=Likelihood; 
  Results(f,2)=length(Mixture_coefficients); 
  Results(f,3)=i; 
  Results(f,4)=j; 
























































%M=Mean of Data 
%C=Scatter Matrix 
%F=Degrees of Freedom 




B.9 Utility for plotting histograms of cluster values 
 
 




 if Labeled(8,i)==cn 
  keep(:,g)=Labeled(:,i); 




























B.10 Utility for plotting cluster means and standard deviations 
 
 













































APPENDIX C: ADDITIONAL PEPTOID SYNTHESES 
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C.1  Peptoids incorporating fluorescent label and iodoacetamide 
 
 Two peptoids FI1 (Fig C.1) and FI2 (Fig. C.2) were synthesized by the methods 
described in Chapter 2 of this thesis.  The key steps are to (i) introduce a C-terminus-
proximal mono-protected diamine, (ii) terminate the growing chain with 2 successive 
peptide couplings of a hexyl spacer (Novabiochem, La Jolla CA) and a carboxy-
fluorescein (Aldrich Chemical Co., Milwaukee WI), and (iii) reveal the C-proximal 
primary amine and iodoacetylate it.   
 MALDI-TOF analyses of the two syntheses (Fig. C.3) indicate that minimal 
desired product was produced in the synthesis of FI1, while a mixture of the 





















































































































2. 6-carboxyfluorescein, HOBt, DIC
1 .TFA/TIS in DCM
2. Iodoacetic acid, DIC in DMF





C, 51.36; H, 5.54; I, 8.61; N, 9.51; O, 24.98  
Figure C.1: Schematic illustration of fluoro-iodo peptoid FI1.  The iodoacetamide is 




















2. 6-carboxyfluorescein, HOBt, DIC
1 .TFA/TIS in DCM
2. Iodoacetic acid, DIC in DMF















































































C, 51.13; H, 5.26; I, 10.19; N, 9.00; O, 24.42  
Figure C.2: Schematic illustration of fluoro-iodo peptoid FI2. The iodoacetamide is 
added near the C-terminus for conjugation to 5′-thiol ODNs. 
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Figure C.3: MALDI-TOF analyses of FI1 (a) and FI2 (b).  The iodoacetamide is 
added near the C-terminus for conjugation to 5′-thiol ODNs. 
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C.2  Peptoids incorporating orthonitrobenzyl moiety 
 
 Two peptoids ON1 and ON2 (Fig. C.4) were produced by the methods described 
in Chapter 2 of this thesis.  They each incorporated the primary amine submonomer 
ortho-nitroaniline (Aldrich Chemical Co., Milwaukee WI) at the second position in an 
attempt to introduce a photocleavage site into the peptoids.  ESI-Quadrapole analyses of 
the product mixtures indicate incomplete yield (Fig. C.5 and Fig C.6(a)).  Exposure to 
broad-spectrum UV light for one hour resulted in no appearance of identifiable cleavage 


















C, 67.42; H, 5.79; N, 12.51; O, 14.29  
Figure C.4: Schematic illustration of ortho-nitro aniline-incorporating peptoid ON1 














Figure C.6: ESI-Q analyses of ortho-nitro aniline incorporating peptoid ON2 before 




C.3  Peptoids incorporating polar, aromatic side groups 
 
 A series of 11 peptoid 5mers (Fig. C.8) were synthesized by the methods 
described in Chapter 2 of this thesis.  Primary amine submonomers were chosen for these 
















Figure C.7: Schematic illustration of four common MALDI matrices. 
 
The resulting peptoids were analyzed by MALDI-TOF mass spectrometry using several 
matrices to determine if they could be detected at lower concentrations than peptoids with 
non-polar, non-aromatic side groups.  The results did not show any sensitivity-enhancing 
effect of these submonomer choices (data not shown).  Two of the peptoids, P057 and 
P061, were conjugated to 5′-thiol ODNs and photocleaved (see Chapter 2, 3), but the 




















































































































































































































P053: Mol. Wt.: 760.49
P055: Mol. Wt.: 856.75 P056: Mol. Wt.: 824.70
P057: Mol. Wt.: 1004.86
P058: Mol. Wt.: 814.67
P060: Mol. Wt.: 792.66 P061: Mol. Wt.: 822.69
P062: Mol. Wt.: 822.69
P064: Mol. Wt.: 1371.22
P063: Mol. Wt.: 810.68  
Figure C.8: Schematic illustration of peptoids incorporating polar, aromatic side 
chains.  
 
